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Abstract
Purpose
The purpose of this dissertation was to determine the acceptability, feasibility, and
potential impact of using Severity of Illness (SOI) mortality risk prediction scores for
initiating end-of-life (EOL) goals-of-care communication in the adult Intensive Care Unit
(ICU). First, an integrative review was conducted to evaluate the psychometric properties
of existing SOI scoring systems and their ability to predict mortality in the adult ICU
population as the basis for clinical care and provider-patient/family communication.
Next, an integrative review of interventions that can guide researchers in reducing
surrogate burden was conducted as the basis for conducting research that may impact
surrogates of dying patients in the ICU. Finally, a mixed-methods study was conducted to
determine the acceptability and feasibility of having providers use SOI mortality
prediction scores for their patients as part of routine care and investigate providers’
intentions to change practice related to goals-of-care communication as a result of
awareness of the scores.
Problem
While healthcare teams recognize that profoundly ill patients in adult ICUs may
die, many families are caught by surprise when their loved one dies in a setting with the
most advanced technology and intense care available. ICU deaths account for about 20%
of patient deaths in US hospitals and this rate is increasing due in part to deficiencies in
EOL care communication that can compromise quality of EOL care and increase resource
utilization. Previous studies suggest that communication about EOL goals-of-care is
infrequent among healthcare providers, patients, and families; often occurs late in the
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course of illness; and relies on family members to act as patient surrogates in discussions.
Furthermore, despite advances in healthcare quality, family members remain more
dissatisfied with communication in the ICU than with other aspects of care. Mechanisms
for increasing the timeliness and frequency of discussions about EOL goals-of-care are
needed.
Specific Aims
Aim 1. Evaluate four valid SOI instruments to determine which instrument, or
combination of instruments, is the best fit for the study site, given providers’ perceived
feasibility of use.
Aim 2. Evaluate the acceptability and feasibility of having providers use SOI
mortality prediction scores for their patients as part of routine workflow and practice.
Aim 3. Evaluate providers’ intentions to change their practice related to goals-ofcare communication with patients and/or their families as a result of awareness of SOI
mortality prediction scores.
Design
First, an integrative review was conducted to evaluate the psychometric properties
of existing SOI scoring systems and their ability to predict mortality in the adult ICU.
This review provided the foundational knowledge needed in the selection of SOI systems
that were used in aim 1. Next, an integrative review of interventions that can guide
researchers in reducing surrogate burden was conducted. This review provided
foundational knowledge needed for designing a study that may impact surrogates of
dying patients in the ICU. Lastly, an explanatory mixed-methods study was conducted to
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determine the acceptability and feasibility of having providers use SOI mortality
prediction scores for their patients as part of routine care and investigate providers’
intentions to change practice related to goals-of-care communication as a result of
awareness of the scores. Self-efficacy theory was used as the theoretical underpinning for
the design of this study, specifically aim 3.
Findings
Based on discrimination alone, the first integrative review found APACHE IV to
be superior, but the VA ICU, SICULA, and SOFA Max were close with ‘very good’
discrimination. The second integrative review revealed six levels of intervention, from
the personal ‘Direct Care of the Surrogate’ to the population-based ‘Legal/Regulatory’
and provided a framework to assist researchers when designing and conducting research
that involves surrogates.
The dissertation study found the use of mortality risk prediction scores as part of
routine workflow and practice to be acceptable and feasible – providers agreed to
participate, patient mortality risk were evaluated by the instrument chosen by the
providers (i.e., the Sequential Organ Failure Assessment - SOFA), and overall,
participants found use of daily mortality prediction scores possible in their setting.
However, there was some disagreement related to the use of SOFA scores as an effective
way for determining patient mortality risk. Based on themes that emerged from
interviews, providers with limited ICU experience were eager and accepting of the
mortality risk scores while those with vast experience found the scores to be an adjunct to
their own intuition; though all acknowledged the benefit of looking at daily scores or
‘trends’. The most substantial of all themes identified was the need to consider SOFA
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scores in relation to patient context; a number alone should not determine mortality risk
and whether a goals-of-care conversation needs to occur.
Conclusion
This dissertation study found that overall, participants indicated that using
mortality prediction scores as part of their daily workflow was acceptable and feasible.
Use of SOFA scores for potentially increasing EOL goals-of-care conversations appears
to be most beneficial for providers with limited ICU experience. Large-scale studies are
needed to determine the effect of using mortality risk predictions on patient EOL
outcomes.

Keywords: End-of-Life, Goals of Care, Poor Prognosis, Mortality Risk, Severity of
Illness, Intensive Care, SOFA, Mixed-Methods
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Introduction
Overview
The goal of this dissertation was to determine if use of a severity of illness (SOI)
scoring system, an instrument that can predict Intensive Care Unit (ICU) patient mortality
risk, affects the timeliness and frequency of end-of-life (EOL) goals-of-care
communication. To accomplish this, the dissertation study aimed to: 1) determine the
acceptability and feasibility of having providers use SOI mortality prediction scores for
their patients as part of routine care, and 2) investigate providers’ intentions to change
practice related to goals-of-care communication as a result of awareness of the scores.
Two integrative reviews were conducted to provide foundational knowledge
needed for designing and conducting the dissertation study. First, an integrative review
was conducted to evaluate the psychometric properties of existing SOI scoring systems
and their ability to predict mortality in the adult ICU. This review provided the
foundational knowledge needed in the selection of SOI systems that were used in aim 1
of the study. Next, an integrative review of interventions that can guide researchers in
reducing surrogate burden was conducted. This review provided foundational knowledge
needed for designing a study that may impact surrogates of dying patients in the ICU.
Background and Significance
While healthcare teams recognize that profoundly ill patients in adult ICUs may
die, many families are caught by surprise when their loved one dies in a setting with the
most advanced technology and intense care available. ICU deaths account for about 20%
of patient deaths in US hospitals and this rate is increasing (1) due in part to deficiencies in
EOL care communication that can compromise quality of EOL care(2) and increase
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resource utilization.(3,4) Previous studies suggest that communication about EOL goals-ofcare is infrequent among healthcare providers, patients, and families; often occurs late in
the course of illness(5,6); and relies on family members to act as patient surrogates in
discussions.(7) Furthermore, despite advances in healthcare quality, families remain more
dissatisfied with communication in the ICU than with other aspects of care. (8,9)
Increased SOI scores are associated with a significant increase in the relative risk
of hospital death.(10) Uncertainties in prognosis (e.g., SOI) are a barrier to EOL
communication in the ICU(11) and family meetings about EOL care can improve family
satisfaction with the EOL experience.(12) However, SOI mortality risk prediction scores
are not routinely calculated and there is little research examining their use for improving
EOL goals-of-care communication. There are multiple valid and reliable SOI scoring
systems that are available for predicting ICU mortality,(13) but there is no consensus about
how or when to use them in patient care and provider-patient/family communication.
In 2014, The Institute of Medicine (IOM) called for major reform to ensure
high-quality, affordable, and sustainable EOL care for Americans. One of the IOM
recommendations includes enhanced provider-patient communication.(14) The high risk
for mortality makes goals-of-care communication in the ICU with patients and/or their
families especially important. Because patients in the ICU are commonly
non-communicative during their intensive illness, their families are often relied upon to
act as decision makers regarding goals-of-care, particularly EOL care. Proactive
communication with the family in the ICU is of importance, especially regarding
prognosis, so they can serve as the patient’s surrogate for informed decision-making.
Moreover, focusing on proactive family conferences earlier in the ICU course, versus
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routine ICU care in which there are no standards for communication timing and
frequency, can reduce psychological distress among family members and reduce
prolongation of dying in the ICU.(15,16) Goals-of-care communication in the ICU is
frequently used to discuss poor patient prognosis. However, previous studies suggest
prediction of mortality by a treating physician is incorrect 50% of the time.(17)
Confounding this uncertainty, physicians often base their assessments of prognosis on
experience rather than on objective measures, and they are often unaware of patients’
EOL preferences.(18) These factors, coupled with lack of communication with patients’
families, can lead to prolongation of dying and prolonged use of intensive resources. (16)
Proactive communication has led to reduced symptoms of anxiety, depression,
and post-traumatic stress disorder for family members who had a loved one die in the
ICU.(15) Decreased resource utilization at the EOL has the potential to decrease the
emotional and financial strain experienced by patients and their families. (19) Although
difficult to hear, most surrogates think the ability of providers to specify numbers (i.e.
ability to recover or risk of dying) would be helpful when communicating prognosis. (20)
By knowing a patient’s mortality risk and communicating it to the family, providers can
direct care toward the patient’s needs and preferences, which could enable a more
positive EOL experience for the patient and their family, such as a focus on palliative
care within the ICU or transfer to a more appropriate unit where family can be more
present and involved in care if they wished. Furthermore, a positive EOL experience for
the patient can limit moral distress experienced by nurses and physicians. (21)
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Unfortunately, no evidence-based standard of care exists for EOL goals-of-care
communication in adult ICUs. Mechanisms for increasing the timeliness and frequency of
discussions about EOL goals-of-care are needed.(22,23)
Specific Aims
Aim 1. Evaluate four valid SOI instruments to determine which instrument, or
combination of instruments, is the best fit for `the study site, given providers’ perceived
feasibility of use.
Aim 2. Evaluate the acceptability and feasibility of having providers use SOI
mortality prediction scores for their patients as part of routine workflow and practice.
Aim 3. Evaluate providers’ intentions to change their practice related to goals-ofcare communication with patients and/or their families as a result of awareness of SOI
mortality prediction scores.
Design and Methods
Both integrative reviews provided foundational knowledge needed for designing
and conducting the dissertation study. This dissertation study used a mixed-methods
explanatory design and took place in a medical-respiratory ICU (MRICU) at a large
academic medical center in Richmond, Virginia. Patients are admitted to this unit for
acute illnesses but commonly exhibit chronic medical conditions as well. Two medical
teams provide patient care, each comprised of an attending physician, a fellow physician,
and a mix of interns, residents, acute care nurse practitioners (ACNPs), and physician
assistants (PAs). These teams provide care for patients throughout their ICU stay, or until
the end of the provider’s assigned time in the MRICU. This study was approved by the
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Institutional Review Board at Virginia Commonwealth University and the Medical
University of South Carolina.
To address Aim 1, attending physicians, fellow physicians, ACNPs, and PAs
working in the MRICU were recruited (target N=6) for a focus group via email as they
are expert providers responsible for medical care of patients admitted to the unit. Based
upon the integrative review completed by the principal investigator(13) (PI) and
implementation feasibility within the study setting, four SOI scoring systems (MPM III,
APACHE IV, SOFA, SAPS III) were presented to the focus group participants. The PI
assumed the moderator role to keep the flow of the conversation on target. (24) Participants
were asked to discuss perceived feasibility of use for each SOI system. Based on
discussion among the participants, the PI then requested consensus on the SOI system of
choice. Participants were also asked to complete a demographic form in Research
Electronic Data Capture (REDCap); descriptive statistics were used to analyze the data.
To address Aim 2, an explanatory mixed-methods approach consisting of a
quantitative questionnaire (target N=12) and a qualitative follow-up interview (target
N=6) were used to determine if providers could feasibly use SOI mortality prediction
scores as part of their routine in the ICU and evaluate their perceptions of acceptability,
feasibility, and potential impact of using the SOI scores. All MRICU fellows, residents,
and intern physicians, as well as all ACNPs and PAs, were recruited on an ongoing basis
via email and face-to-face for this portion of the study; attending physicians were
excluded due to their short length of rotations in the ICU. The PI or research assistant
(RA) calculated mortality risk percentages for MRICU patients admitted under the care
of study participants for ten consecutive days, using the free web-based calculator. To
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ensure consistency with the chosen system’s published protocol, the PI developed a
user’s manual for the PI and RA to use. The PI and RA reviewed a random selection of
25% of each other’s calculations to examine inter-rater reliability. Calculated scores were
limited to three days per patient for feasibility purposes. Mortality risk percentages were
shared with participants on a card each morning prior to team rounding. Based upon the
integrative review conducted by the PI, scores lacked specific identifiers and
interpretation; this was done to reduce surrogate burden related to insufficient knowledge
in the instance the cards were misplaced and discovered by the surrogate. Reference cards
were provided during study enrollment for providers for interpretation of the scores.
Following the ten-day period, participants received a link to a REDCap questionnaire
asking about acceptability and feasibility of using the SOI mortality risk prediction scores
as part of their workflow and practice.(25) Results of the questionnaire were retrieved from
REDCap as descriptive statistics. Additionally, participants who did not also participate
in the focus group were asked to complete the same demographic form in REDCap.
To further explain the acceptability and feasibility questionnaire results and to
address Aim 3, all participants who completed a questionnaire were contacted
approximately one week later asking for their participation in a follow-up interview.
Those agreeing to participate were scheduled for face-to-face interviews with the PI using
open-ended questions. Although specific topics were covered during the interview, the PI
allowed the participant’s cues to determine the flow.(26) Each interview was voice
recorded digitally and transcribed verbatim. A qualitative descriptive approach was used
to analyze the interview data.(27,28) To accomplish this, a fluent process occurred wherein
transcripts were reviewed following every 2-3 interviews; they were read repeatedly to
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achieve immersion, exact words that captured key thoughts were highlighted, notes of
impressions were made, and key themes were identified that emerged from the notes. As
themes emerged, the PI asked for confirmation from subsequent participants. The
resulting themes from all transcripts were defined and exemplars were identified. To
ensure the resulting themes were credible, the PI discussed the findings with experts who
were familiar with the subject under study. Lastly, final themes and exemplars were
examined to help explain the results of the acceptability and feasibility questionnaire.
Theoretical Framework
Self-efficacy theory(29) was used as the theoretical underpinning for the design of
this study, specifically aim 3. The PI used self-efficacy as a guiding theory when
collecting data on whether awareness of mortality risk prediction scores contributed to a
provider’s intention to change their practice regarding the timeliness and frequency of
EOL goals-of-care communication. Specifically, providers were asked about what they
did with the scores they were provided and what impact, if any, they felt they could have
on a patient’s EOL experience in the ICU.
Self-efficacy theory provides an understanding of how individual’s beliefs
concerning his or her abilities can affect their own behavior.(30) Therefore, a person’s
motivation and performance in relation to completing a task is dependent upon how
effective they believe they can be. Related to this study, a provider with high self-efficacy
would believe that they are capable of positively impacting the quality of their patient’s
EOL and are motivated to do so. However, a provider with low self-efficacy does not
believe they are capable of positively impacting the quality of their patient’s EOL, and
therefore, would not be motivated to put forth such effort.
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Manuscripts
Manuscript 1. An array of SOI scoring systems are available to predict mortality
with no clear consensus on which system should be used for general adult ICU patients,
and how the system should be integrated into daily patient care and providerpatient/family communication. This integrative review synthesized the literature that
evaluated the psychometric properties of existing SOI scoring systems and their ability to
predict mortality in the adult ICU population as the basis for clinical care and providerpatient/family communication. This review provided the foundational knowledge needed
in the selection of SOI systems that were used for the aim 1 focus group.
Manuscript 2. Although research is needed in the area of EOL, many people are
incapable of giving consent for research during their EOL due to incapacity. Although
there has been a shift in support for surrogate decision making in research, there is a need
to minimize surrogate burden throughout the research trial. The purpose of this
manuscript was to discuss the current state of research consent and continued enrollment
for incapacitated persons through an integrative review of the literature. This review
provided foundational knowledge needed for designing a study that may impact
surrogates of dying patients in the ICU.
Manuscript 3. This manuscript is a report of the findings of the dissertation
research. This study evaluated the acceptability and feasibility of having providers use
mortality prediction scores for their patients as part of their routine practice as well as
investigated intentions to change practice, related to goals-of-care communication, as a
result of awareness of the scores.
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Abstract

Introduction: Deficiencies in end-of-life communication in the adult ICU persist despite
an estimated one in five patient deaths in the hospital occurring in the ICU. Discussions
regarding prognosis typically are prioritized according to a patient’s greater risk for
mortality. An array of severity of illness (SOI) scoring systems are available to predict
mortality with no clear consensus on which system should be used for general adult ICU
patients, and how the system should be integrated into daily patient care and providerpatient/family communication.
Objective: This integrative review synthesizes the literature that evaluates the
psychometric properties of existing SOI scoring systems and their ability to predict
mortality in the adult ICU population as the basis for clinical care and providerpatient/family communication.
Methods: Using strategies specific to the integrative review method proposed by
Whittemore and Knafl, a systematic search strategy was used to review and analyze the
literature.
Results: A total of 969 articles were identified with seven meeting all inclusion criteria.
Based on discrimination alone, this review found APACHE IV to be superior, but the VA
ICU, SICULA, and SOFA Max were close with “very good” discrimination.
Conclusions: Given the differences among ICUs, until a SOI system is used with success
in a respective setting, with that ICU’s particular case-mix, the system’s validity for that
setting will remain uncertain. Future research is needed to examine the role of SOI
scoring systems in the ICU for the purpose of increasing the timeliness of prognosis
communication with the patient and/or family.
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Introduction
An estimated 20% of patient deaths within hospitals occur in Intensive Care Units
(ICU), and this trend continues to increase.1 Due to the critical and unstable nature of
most patients’ illness in the ICU, frequent communication with the patient and/or family
is needed regarding the patient’s prognosis. However, due to the complex and fast-paced
nature of the ICU, discussions regarding prognosis typically are prioritized according to a
patient’s greater risk for mortality.
Mortality risk is defined as the estimate of the likelihood of a patient dying while
in the hospital.2 There is evidence to suggest that providers are able to use their subjective
experiences to gauge a patient’s mortality risk.3 However, because this is based on
subjective experiences and not quantitative data, additionally assessing mortality risk
with utilization of a score or rating that reflects a prognostic model may be beneficial. By
accurately knowing a patient’s mortality risk, providers may be able to direct care toward
the patient’s needs and preferences.
In 2014, the Institute of Medicine (IOM) called for a major reform to ensure highquality, affordable, and sustainable end-of-life care for Americans.4 One of their key
recommendations included enhanced provider-patient communication. Although
prognostic models were developed to assess ICU performance by comparing observed
and risk-adjusted hospital mortality, these models can be used to guide providers, patients
and families in joint decision-making.5 Prognostic models have the ability to combine
multiple characteristics related to a patient and their disease to predict a prognostic
outcome.6 An array of prognostic models are available for calculating severity of illness
scores, which can be converted to a mortality risk percentage; however, there is no clear
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consensus on which prognostic model should be used for general, meaning not disease
specific, ICU patients, and how the model should be integrated into daily patient care and
provider-patient communication. Because the term “models” as it relates to
prognostication can be confusing and different terms are used to describe the models
within the literature, the models reviewed will hereafter be referred to as ‘severity of
illness (SOI) scoring systems’. This integrative review synthesizes the literature that
evaluates the psychometric properties of existing SOI scoring systems and their ability to
predict mortality in the adult ICU population as the basis for clinical care and providerpatient communication.
Methods
Based on the methods proposed by Whittemore and Knafl,7 an integrative review
was completed. A systematic search of PubMed, CINAHL (EBSCOHost), Web of
Science, and ProQuest Dissertations and Theses occurred in consultation with a
university reference librarian. In addition, a search occurred of reference lists for the
retrieved publications to identify published articles addressing SOI scoring systems,
along with discussions with colleagues familiar with this literature to hand pull additional
articles. The following inclusion criteria guided the search: articles written in English and
addressing an adult population. Thus, mortality risks for children were not part of this
review. The search was separated into two concept groups. One group encompassed the
terminology used to describe “severity of illness” and another covered the terms relevant
to “hospital mortality.” Medical Subject Headings (MeSH) and equivalent controlled
vocabulary and keywords were utilized in each database as appropriate. The initial search
yielded 865 articles (Figure 1); their titles, key words, and/or abstracts were reviewed to
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assess their relatedness to the inclusion criteria of general adult ICU patients within the
last ten years. The decision to exclude those greater than ten years old was due to the
changing landscape (i.e. increased technology and patient acuity, updates in provider
practice) of the adult ICU in the previous decade. Articles also were excluded if they
were a duplicate or were not related to adults (those not caught by the initial search), or if
there was a more recent publication of the same work. Articles that discussed single
variables as a predictor of mortality were excluded due to the variability of patients’
disease etiology, presentation, and other health status; a single predictor or variable is not
likely to give an adequate estimate of prognosis.5 In addition, articles that narrowed a
study to the elderly population only were excluded because of the range in age of today’s
ICU patients and the desire to review SOI systems applicable to the general adult
population. This review of titles, abstracts, and key words resulted in 79 full texts articles.
The investigator decided to exclude articles that discussed work outside of the United
States (US) due to noted vast international differences in patient populations and cultural
needs, along with clinical sites and administration. In addition, articles that did not
discuss the specific use of a SOI scoring system and its psychometric properties were
excluded, leaving seven articles for the final review.
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Figure 1. Literature Review Search
Additional records identified
through other sources
(n= 7)

Records identified through
database searching
(n= 962)

Minus duplicates;
Titles/abstracts screened
(n= 865)

Records excluded
(n= 786)

Full-text articles assessed for
eligibility
(n= 79)

Records excluded
(n= 72)

Studies included in
Integrative Review
(n= 7)

A matrix (Table 1) was used to extract data from the resulting articles.
Descriptions of the SOI scoring systems with their reported reliability, validity, and
feasibility were included, along with the determined level of evidence. This review
provides a descriptive synthesis of the literature on the psychometric properties of SOI
scoring systems that predict adult ICU patient mortality risk.
Results
Each of the seven articles included in this integrative review represented at least
one SOI scoring system used to predict mortality in adult ICU patients. Altogether, nine
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SOI systems were evaluated in the review (Table 1) and those studies reported results
with medium to high level evidence.8
Severity of Illness (SOI) Scoring Systems
The Acute Physiology and Chronic Health Evaluation (APACHE), Mortality
Probability Model (MPM), and the Simplified Acute Physiology Score (SAPS) were the
main SOI scoring systems discussed in the literature. Primarily due to the limited
predictive ability of their older versions, updates to these systems, along with other newly
developed systems, were most commonly reported and used for evaluation in the
literature.
APACHE (Acute Physiology and Chronic Health Evaluation). The APACHE
system was first developed in 1981 by researchers at The George Washington University
Medical Center to measure severity of illness in groups of critically ill patients to
compare patient outcomes, evaluate new therapies, and study ICU utilization.9 The most
current version, APACHE IV, uses physiologic data from the first 24 hours after ICU
admission.10 It incorporates 142 predictor variables, 116 admission diagnoses, and 17
physiological variables over the patient’s first 24 hours in the ICU. 11 Predictor variables
include age, gender, acute physiology score variables (laboratory results, vital signs,
Glasgow Coma Scale (GCS)), chronic health variables, ICU admission diagnosis and
source, length of stay prior to ICU admission, GCS score rescaled (or inability to assess),
PaO2/FiO2 ratio, whether the patient had emergency surgery, mechanical ventilation
status, and whether the patient is post-coronary artery bypass grafting (CABG), including
the number of any grafts, whether an internal mammary graft was used, and whether the
patient had diabetes prior to the CABG or a myocardial infarction during that

PREDICTING ICU PATIENT MORTALITY

20

hospitalization. The APACHE II, which relies on 12 routine physiological variables, age,
and previous health status,12 remains widely used in clinical practice, primarily related to
provider familiarity with the earlier version and some studies that questioned the
calibration of the updated version, APACHE IV.13
MPM (Mortality Probability Model). The MPM system was first developed in
1985 by researchers at Baystate Medical Center to predict hospital mortality to assist with
triage decisions, compare various ICUs and their utilization, and determine
aggressiveness of care through communication with families. 14 The most current version,
MPM III, has 16 predictor variables plus seven interaction terms that include
physiological variables, chronic diagnoses, acute diagnoses, age, code status (and
whether the patient has received CPR), mechanical ventilation status, and whether a
medical or unscheduled surgical admit occurred.15 The MPM III uses physiologic data
from one hour before and one hour after ICU admission10 but no initial diagnosis is
needed.16 A modified and recalibrated version of the MPM III was developed by the
National Quality Forum.17 The NQF model has 28 additional interaction terms, as well as
different patient exclusions when compared to the MPM III.
SAPS (Simplified Acute Physiology Score). The SAPS system was first
developed in 1984 by researchers in France to classify patients into groups of comparable
probability of death to facilitate inter-ICU comparisons of treatment and management.18
The most current version, SAPS 3, uses physiologic data collected within one hour
(before or after) of ICU admission.19 Predictor variables include age, comorbidities, preICU location, pre-ICU length of stay, pre-ICU major therapeutics, reason for ICU
admission, planned/unplanned admission, infection at ICU admission, surgical status, site
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of surgery if applicable, GCS, laboratory results, vital signs, and
ventilation/oxygenation.19,20 A previous version, although still prominent in the literature,
is SAPS II which includes only 17 variables: 12 physiology variables, age, type of
admission, and three underlying disease variables.21 The SAPS II relies on the most
severe data in the first 24 hours following ICU admission. More recently, an electronic
version of the SAPS 3 was developed. The eSAPS3 provides a risk adjustment score
using only data available from the electronic health record. 22 For this system, some SAPS
3 variables are pulled directly from the electronic record, and other variables are adapted
if the SAPS 3 item requires data that are not an exact fit with the medical record or data
that must be manually reviewed. For example, the SAPS 3 variable of infection at ICU
admission is adapted to diagnosis coding and antibiotic utilization and timing within the
eSAPS3.
SOFA (Sequential Organ Failure Assessment). The SOFA scoring system was
originally designed in 1994 by the European Society of Intensive Care Medicine as a way
to quantitatively describe the degree of organ dysfunction/failure and assess the effects of
new therapies for septic patients.23 However, it was discovered that it could be applied
just as well in non-septic ICU patients.24,25 The SOFA assigns 1-4 points to the following
organ systems depending on the level of organ dysfunction: circulatory, respiratory,
renal, hematology, hepatic, and central nervous system.26 Differentiations are made based
on the scores used.27 The max SOFA is the highest total SOFA measured in a prespecified time interval, the mean SOFA is the average of all total SOFA scores in a prespecified time interval, and the delta SOFA is the total max minus admission SOFA. Data
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are typically collected upon ICU admission and throughout the ICU stay, with the most
abnormal values for each day being used for scoring. 25
VA ICU (Veterans Affairs ICU). The VA ICU system was first developed in
2005 by researchers using VA ICU patients within 17 geographically diverse regions in
the US to identify differences in indicators of performance among the ICUs.28 This riskadjustment system uses physiologic data collected during the 24 hours surrounding ICU
admission.29 Predictor variables include age, diagnosis/procedure, operative/nonoperative, comorbidities, laboratory data, and admission source. Compared to a previous
version, some diagnoses designated as “other” were given specificity. 29 In addition, the
ability to designate the source of admission to the ICU was added.
SICULA (Super ICU Learner Algorithm). The SICULA was developed in
2015 by researchers using patients admitted to an ICU at Beth Israel Deaconess Medical
Centre, and validated with patients admitted to an ICU in France, as a method for
predicating hospital mortality for patients in ICUs.30 This is an ensemble machine
learning technique that uses multiple learning algorithms using physiologic data collected
within the first 24 hours after ICU admission.30 Predictor variables include clinical data
retrieved from the electronic health record (vital signs, progress notes, intravenous drip
medications, fluid balances, demographics, imaging results, physician orders, laboratory
results, discharge summaries, and International Classification of Disease-9 codes) and
high-resolution physiological data from bedside monitors (waveforms and derived
physiological measurements).
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Assessing Model Performance
Health statisticians typically assess the performance of ICU SOI scoring systems
to predict mortality by examining the area under the receiver operating characteristic
curve (AUC) for discrimination and the Hosmer-Lemeshow (H-L) statistic for
calibration.31 The AUC is a measure of how well a SOI system differentiates between
groups, for example, between survivors and non-survivors.31 An AUC of 1 is considered
perfect, 0.90-0.99 excellent, 0.80-0.89 very good, 0.70-0.79 good, 0.60-0.69 moderate,
and less than 0.60 poor, with 0.5 equivalent to chance. Calibration is the correlation
between the actual and predicted outcome for the entire range of risk and is considered to
be good if the H-L statistic p-value is greater than 05.32 Because the H-L statistic can be
influenced by sample size, accuracy is sometimes assessed by measuring the average
distance, or residual, between the observed outcome and its predicted probability for each
patient.27 The Brier score is one method for measuring accuracy by squaring the mean of
the residual values, where a lower score indicates better performance. However, since the
Brier score can be affected by the incidence of mortality, more recent studies have
included a modified Brier’s score that adjusts for this contingency; that modified score
represents the percent reduction in deviation when using a specific predictive model
versus assigning probability equal to the incidence rate, and a higher percentage
reduction indicates better accuracy17. Additionally, an intercept and calibration slope
(known as Cox calibration test) has been used to overcome the shortcomings of the H-L
statistic.30 In addition, a standardized mortality ratio (SMR) often is reported to indicate
the observed deaths as compared to predicted mortalities; the SMR is calculated by
dividing the observed mortality rate by the mean predicted mortality rate. 33
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Validity
All SOI scoring systems included within the seven articles included in the final
analysis had a minimum of “good” discrimination as determined by the AUC (> 0.70),
with the exception of SOFA when it was delineated out by systems (AUCs “moderate” at
0.655 for hepatic and 0.684 for coagulation).27 Based on reported AUCs, the APACHE
IV had the best discrimination among all SOI systems (AUC range 0.88-0.892)10,11,17 but
the VA ICU, SICULA, and SOFA Max were not far behind with “very good”
discrimination (AUC > 0.80).27,29,30
Across the nine SOI systems included, calibration was not as consistent as
discrimination. Examining the reported H-L statistics and associated alternative statistics,
four of the seven SOI scoring systems (SICULA, SOFA Max, eSAPS 3, VA ICU)
revealed adequate calibration within their single studies.22,27,29,30 However, less than
desired calibration was discovered in others. Calibration of the APACHE IV (H-L chisquare 219, adjusted Brier 31%) was superior to the MPM III (H-L chi-square 554,
adjusted Brier 16.1%) and NQF (H-L chi-square 760, adjusted Brier 17.8%) in one
study17 but the APACHE IV (H-L 22.4, p= 0.01) was inferior to the MPM III (H-L 9.8,
p= 0.5) and SAPS II (H-L 18.1, p= 0.05 which also indicates poor performance) in
another.10 An acceptable SMR was reported for the APACHE IV (1.03), MPM III (1.04),
and SAPS II (1.04) in one study but values reported indicate a higher rate of observed
deaths than actually expected.10
Reliability
Only two of the seven articles reported some measure of scoring index reliability.
In the study that compared the MPM III, SAPS II, and APACHE IV, auditors were used
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to re-abstract data from a random sample of patients in the study to assess for interrater
reliability.10 High percentage agreement and K statistics indicated strong interrater
reliability, with the exception of GCS and APACHE IV reasons for ICU admission. In
the study examining the eSAPS3, percentage agreement was examined to assess for
differences between the electronic and manual components of the scoring system, which
revealed a discordance of 7.9% on average across all individual components. 22
Although no reliability indicators were reported for the studies included in the
systematic review of SOFA scoring systems, a third reviewer was used to resolve any
differences between the two reviewers conducting the literature search. 26 Inter-observer
agreement Kappa was 0.94.
Feasibility
Six of the seven articles included information on the feasibility of using various
SOI scoring systems. Although manual entry of predictor variables can be time
consuming (i.e. 37.3 minutes for APACHE IV)10 and requires training for those entering
the data,10,11 many of the articles discussed the ability of computerized systems to
decrease this workload10,11,17,22,29,30 and, thus, time requirements (i.e. 1.5 minutes for
APACHE IV).17 However, the electronic system must be able to pull information
automatically from the electronic health record (EHR), requires sufficient programming
to guide the system in case of missing or non-valid data,10,22,29,30 and may require the
purchase of a licensed system (i.e. APACHE IV).11 Systems such as the SAPS 3 and
SICULA are available free of charge but still require a computer system capable of
handling their complexities.22,30
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Discussion

This integrative review identified nine SOI scoring systems that can be used to
predict mortality for patients admitted to the adult ICU. Previous reviews have presented
the development of a SOI system or compared similar systems. However, this review
includes all available articles within the last ten years, including evaluations of updated
and new SOI systems better suited to address the constantly changing ICU.
Validity
To compare SOI scoring systems, we often rely on reported discrimination and
calibration of the systems. Good to strong discrimination was reported for all SOI
systems in this review, except for SOFA when broken down into specific organ systems
(some AUCs moderate).27 However, specific organ system scores should not be used in
isolation when calculating mortality risk predictions. Adequate calibration was
inconsistent across studies. It is likely impossible for any system to have perfect
calibration or discrimination because ICU patients can be unpredictable despite our best
prognostications. Because the goal is to predict outcomes for individual patients, not to
compare quality of care between ICUs, good discrimination (as reported for the SOI
systems reviewed), is most important. However, we cannot negate that recalibration of all
systems used to predict mortality should regularly occur to reflect current ICU practice
and patient demographics.
Although the literature search was restricted to the US, a question regarding the
generalizability of the findings remains. The APACHE IV, MPM III, eSAPS 3, SICULA,
and VA ICU were developed with US patients,11,15,22,29,30 but sample diversity varied
greatly. APACHE IV was developed using a sample from 104 US hospitals 11 while the
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SICULA sample was from only one US hospital in Boston. 30 However, the SICULA was
externally validated with a sample from a hospital in France, perhaps making their
findings more generalizable. SAPS 3, which provides the basis for the eSAPS 3, was
developed with a sample from 5 continents, including North America.34 This may make
the eSAPS 3 more generalizable, but it is difficult to determine because their sample was
restricted to 21 California hospitals.22 Additionally, both studies using SOFA in the
systematic review included in this review had samples incorporating patients from both
the US and various other countries,27 again perhaps making SOFA more generalizable.
Lastly, there is no way to ascertain whether the studies in the US are generalizable to the
US population due to potential selection bias. For example, the APACHE IV was
developed only using hospitals with APACHE capabilities, which requires expensive
software.11 The VA ICU was developed using a sample from 42 regionally diverse ICUs
but its generalizability is likely restricted due to the nature of VA patients (predominantly
male and greater than 64 years old).29
When considering generalizability, SOI scoring system exclusions must also be
considered. Many of the SOI systems (eSAPS 3, APACHE IV, NQF, MPM III) exclude
repeat ICU admissions within the same hospitalization and transfers from another
facility.11,17,22 Other nuances also exist, such as the MPM III excludes acute myocardial
infarction and cardiac surgery patients.35
Reliability
Reliability was only reported in three of the articles. However, given the
complexity of SOI systems, it is understandable that consistency is not commonly
examined or reported. Often times, reliability is dependent upon data abstraction for the
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scoring system, such as consistency and clarity of ICU charting. 36 For example, in
previous studies that examined reliability, interrater reliability was high for objective
elements such as patient demographics37 but lower for other elements that were
dependent on the clinical skills of the examiner and may be influenced by the patient’s
medical conditions, such as GCS.38
Feasibility
Although all SOI scoring systems included in this review had reasonable validity
and reliability (when reported), the logistics of using such systems cannot be
underestimated. The feasibility of any facility staff manually entering accurate data
required for SOI scores is unlikely. Manual entry of accurate and real-time data could be
a barrier to feasibility. Therefore, whether hospitals can afford the software, electronic
health record, and programming needed must be considered. Although automatic
calculations can be done, some systems have variables that cannot be automatically
populated and must be manually entered;22 training for anyone involved with data
collection can be expensive.39 Additionally, electronically populating data may save time
but can lead to errors. For example, if a patient’s pulse oximeter has a poor signal, an
inaccurate low number could be automatically recorded in the EHR; although the same
could occur with manual entry due to human error. Although a single number may not
lead to an invalid calculation, SOI scoring systems with a large number of variables could
have multiple inaccuracies, likely leading to a significant under or over-prediction (more
likely) in mortality risk.
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Other Considerations
Among the SOI scoring systems presented in this review, data collection time
points vary greatly. Some systems rely on patient data one hour before and/or one hour
after ICU admission10,34 while others collect data within or surrounding the first 24 hours
after ICU admission.11,29,30 SOFA is the only SOI system reviewed that was validated
using ICU admission data and sequentially for subsequent ICU days using the most
abnormal data from the previous 24 hours.25 There is evidence to suggest that the
combination of admission and daily scores may have superior prognostic performance
than each instrument alone.27 Additionally, evidence suggests that SOI systems with a
large number of predictor variables being used for 24 hour data (versus within one hour)
collection likely leads to better case-mix adjustment and better predictive ability.17
However, data from within one hour of ICU admission is less likely to be affected by
medical care after admission to the ICU.10
Limitations
Although multiple researchers reviewed this manuscript, a single reviewer was
used to compile the literature which could have influenced the outcome of the review. To
overcome this potential bias, specific inclusion and exclusion criteria were used and data
analysis occurred using the methods specified by Whittemore and Knafl. 7 Lastly, one
problematic issue in the literature is the variety of terminology used to identify SOI
systems. A research librarian was used to conduct a search which included terminology
used to describe “severity of illness” to reduce the risk of missing an articles due to
differences in terminology.
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Conclusion

This is the first known attempt at integrating a review of current SOI scoring
systems used to predict mortality for patients admitted to the adult ICU. Based on
discrimination alone, this review found the APACHE IV to be superior, but the VA ICU,
SICULA, and SOFA Max were all close behind with “very good” discrimination.
Calibration, however, was not as consistent with any of the systems reviewed. The
APACHE IV has many variables that likely overcome the potential case-mix
shortcomings, but the expense of the system, compared to other non-proprietary systems,
may be a limiting factor for some institutions. Regarding feasibility, the complexity of
the computer systems and/or programming needed for the APACHE IV, SICULA, and
VA ICU must be considered. The SOFA has far less variables and has gained recent
popularity due to its role in the updated sepsis guidelines,40 so it is well-known to ICU
providers. Additionally, providers often prefer the ability to look at trends in data and
SOFA is the only system reviewed here that provides daily scores. Regardless, given the
differences among ICUs, until a SOI scoring system is used and calibrated in a respective
setting, the scoring system’s validity for that setting will remain uncertain.
All of the SOI scoring systems included in this review proved to be valid in their
respective studies. Although we acknowledge the importance of considering the
feasibility of using a specific SOI system and the patient context in which they are used,
identifying patients at increased risk for mortality may help initiate earlier goals-of-care
discussions with patients and/or their families. Proactive communication has been shown
to reduce psychological distress among family members and reduce prolongation of
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dying for patients in the ICU.41,42 Future research is needed to examine the role of SOI
scoring systems in the ICU for this purpose.
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Table 1. Summary of Findings
Prognostic
Model
Reference

Research
Subjects

Study
Purpose/Design

Validity

Comparison of
the Mortality
Probability
Admission
Model III,
National
Quality Forum,
and Acute
Physiology and
Chronic Health
Evaluation IV
Hospital
Mortality
Models:
Implications for
National
Benchmarking

Patients from the
APACHE database for
ICU admissions 20082012. Included 99
ICUs at 47 US
hospitals. However,
final n= 55,304 due to
missing MPM III data
(55 ICUs in 38
hospitals).

Purpose: To compare the
accuracy of the original
MPM III, NQF
modification of the MPM
III (NQF Model), and
APACHE IV for comparing
observed and riskadjusted hospital
mortality predictions.

Comparison of models:
APACHE IV AUC= 0.88,
Hosmer-Lemeshow chisquare= 219, Adjusted
Brier= 31.0%.
MPM III AUC= 0.81,
Hosmer-Lemeshow chisquare= 554, Adjusted
Brier= 16.1%.
NQF AUC= 0.80,
Hosmer-Lemeshow chisquare= 760, Adjusted
Brier= 17.8%.

17

Models: MPM
III, NQF,
APACHE IV

ICUs included
medical-surgical,
surgical, medical,
coronary care, and
neurological units.
Patients with ICU
readmissions, less
than 18 years of age,
admitted for an MI,
or admitted for
cardiac surgery or
trauma were
omitted.

Design: Retrospective
paired analysis of day one
hospital mortality
predictions.

Reliability

Not Reported

Feasibility

Level of
Evidence8

Referenced Only:
Manual collection of
MPM III data (11.1
minutes) versus
APACHE IV (37.3
minutes) per
patient.10
With electronic
automated
collection capability,
APACHE IV data
collection time is
reduced (1.5
minutes).43

Level 3: Large
study with
inception
cohort. Modelspecific
exclusions
leading to
exclusion of a
large number of
patient data.
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Prognostic
Model
Reference

Research
Subjects

Study
Purpose/Design

Validity

Reliability

Feasibility

Variation in ICU
Risk-Adjusted
Mortality:
Impact of
Methods of
Assessment and
Potential
Cofounders 10

11,300 patients that
were discharged from
the hospital or died
after an eligible ICU
admission in 25
California hospitals
(with similar
characteristics of all
California hospitals)
from 2001-2004.

Purpose: To compare the
predictive accuracy,
reliability, and data
burden of existing ICU
risk-adjustment models,
including the MPM III,
SAPS II, and APACHE IV.

Comparison of models:
MPM III AUC= 0.809,
Hosmer-Lemeshow
statistic= 9.8 (p=0.5),
SMR= 1.04.
SAPS II AUC= 0.873,
Hosmer-Lemeshow
statistic= 18.1 (p=
0.05), SMR= 1.04.
APACHE IV AUC= 0.892,
Hosmer-Lemeshow
statistic= 22.4 (p=
0.01), SMR= 1.03.

Auditor reabstracted model
data from a 5%
random sample of
patients. Interrater
reliability between
data abstractor and
auditor: 91.5-98.8%
agreement, K
statistic range 0.720.96 with GCS (K=
0.55) and APACHE
reason for ICU
admission (K=0.51)
lower.

Mean manual data
collection times:
MPM III= 11.1
minute, SAPS II=
19.6 minutes,
APACHE IV= 37.3
minutes.
Manual abstraction
warrants training of
data collectors.
Advanced system
capabilities required
for automated data
collection from EHR.

Models: SAPS II,
MPM III,
APACHE IV

Patients that had
missing data, were
less than 18 years of
age, were not
admitted to an adult
ICU, did not stay in
the ICU for at least
four hours, or
experienced a burn,
trauma, or a CABG
were omitted.

Design: Retrospective
chart review. Cohort was
randomly divided into
development (60%) and
validation (40%) samples.
Logistic regression used
to re-estimate the
coefficients of the models
in the development
sample.

Level of
Evidence8
Level 2: Study
with inception
cohorts and
randomized
division of
development
and validation
groups.
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Prognostic
Model
Reference

Research
Subjects

Study
Purpose/Design

Validity

Acute
Physiology and
Chronic Health
Evaluation
(APACHE) IV:
Hospital
Mortality
Assessment for
Today’s
Critically Ill
Patients 11

110,558 consecutive
ICU admissions 20022003 at 104 ICU
(medical, surgical,
cardiothoracic,
neurologic, trauma)
or coronary care
units at 45
geographically
diverse hospitals in
the US that had
APACHE III
computerized data
systems.
Patients admitted for
less than four hours,
with burns, less than
16 years of age, posttransplantation
(except renal and
hepatic), no acute
physiology score
during first 24 hours
of ICU admission, and
those hospitalized
greater than 365 days
or transferred from
another ICU were
omitted.

Purpose: To develop and
validate the APACHE IV by
using predictor variables
similar to the APACHE III
with new variables added
and different statistical
modeling used.
New diagnoses were
added and new predictor
variables included
whether a patient was
mechanically ventilated,
whether a patient with an
MI received thrombolytic
therapy, adjustments for
prognostic implications of
GCS and Pa02/Fi02, and
impact of inability to
assess GCS due to
sedation or paralytics.

Comparison among
models in validation set
(non-CABG surgery
patients): APACHE IV
SMR
observed/predicted
mortality= 0.997 (p=
.79), AUC= 0.88,
Hosmer-Lemeshow chisquare= 16.8 (p= .08).
APACHE III (I) SMR
observed/predicted
mortality= 0.923 (p=
<.001), AUC= 0.870,
Hosmer-Lemeshow chisquare= 124.6 (p=
<.001).
APACHE III(H) SMR
observed/predicted
mortality= 0.799 (p=
<.001), AUC= 0.868,
Hosmer-Lemeshow chisquare= 635.4 (p=
<.001).
SMR
observed/predicted for
patients admitted after
CABG surgery= 0.997
(chi-square= 0.002, p=
.96).

Model: APACHE
IV

Design: Observational
cohort study. Sample was
randomly divided into
training set (60%) and
validation (40%) groups.
APACHE III, versions H
and I were applied to the
validation data set for
comparison.

Reliability

Not Reported

Feasibility

Level of
Evidence8

Available on a free,
public website.
Dropdown options
allow for relatively
quick entry but
complexity of
variables warrants
training for data
collection (training
manual available).
Requires use of
purchased APACHE
system for
automated
collection of acute
physiology score
variables and
laboratory data.

Level 2: Large
study with
inception
cohorts and
randomized
division of
training set and
validation
groups.
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Prognostic
Model
Reference

Research
Subjects

An Electronic
Simplified
Acute
Physiology
Score-Based
Risk
Adjustment
Score for
Critical Illness in
an Integrated
Healthcare
System 22

67,889 patients at
least 18 years old
who had an ICU
admission between
January 1, 2007 and
December 24, 2011
to one of 21 Kaiser
Permanent North
California Healthcare
System facilities.
Patients with a
repeat ICU admission
or transfer from an
outside facility were
excluded.

Model: eSAPS3

39
Study
Purpose/Design
Purpose: Development
and performance
assessment of an
electronic ICU risk
adjustment score based
on the SAPS 3.
Design: Cohort was
randomly divided into
derivation (40%) and
validation (60%) samples.
At baseline, groups had
similar characteristics.
Coefficients from logistic
regression in the
derivation group were
applied to the validation
group and tested.
Performance was
evaluated using published
SAPS 3 global and North
American coefficients.

Validity

Reliability

Feasibility

AUC= 0.80. After
expanding the
laboratory value
retrieval window, AUC=
0.81.
For the validation data
set, AUC= 0.82,
Hosmer-Lemeshow chisquare= 6.7 (p= .57).
When limited to each
hospital, AUC range=
0.77-0.85, HosmerLemeshow chi-square
range= 5.7-43.6.
When separated by
cohorts grouped per
year, the HosmerLemeshow chi-square
was not significant for
2009 (=11.3), 2010
(=12.8), or 2011 (=6.9)
using p> 0.10.

Manual review of
200 randomly
selected ICU
episodes formed by
deciles of the
eSAPS3 scores and
assessed by percent
agreement and K
scores revealed
discordance
between electronic
and manual
components of
SAPS 3 of 7.9% on
average across all
individual
components.

Allows for
automated
extraction of data
based on SAPS 3
which is
nonproprietary.
Requires use of EHR
with data extraction
capabilities.
Requires adaptation
of some variables
that cannot be
directly linked to
EHR.

Level of
Evidence8
Level 2: Large
study with
inception
cohorts and
randomized
samples within
the controlled
cohort.
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Prognostic
Model
Reference

Research
Subjects

Study
Purpose/Design

Validity

Reliability

Evaluation of
SOFA-based
Models for
Predicting
Mortality in the
ICU: A
Systematic
Review 27

Two studies included
patients from the US
(in combination with
other countries).
Study one= 748 ICU
patients from 40 ICUs
(1 from US, 35 from
Europe, 1 from
Australia, 3 from
South America) May
1995.44
Study two= 1449
patients from 40 ICUs
(1 from US, 35 from
Europe, 1 from
Australia, 3 from
South America) May
1995.45

Purpose: To
systematically review
studies evaluating the
performance of SOFA for
predicting mortality for
patients in the ICU (article
n= 18).

Study one examined
SOFA sequentially
(Total Max SOFA AUC=
0.84, HosmerLemeshow H p-value=
0.95, C p-value= 0.54).
Study one also
compared Max SOFA
alone (AUC= 0.841)
with Max SOFA and
infection (AUC= 0.845),
and Max SOFA and
infection and age
(AUC= 0.853).
Study two examined
SOFA at admission or a
fixed time thereafter
(AUC= 0.772) and
sequentially (Total Max
SOFA AUC= 0.847,
Delta SOFA AUC=
0.742). Study two also
evaluated individual
components of SOFA.
Cardiovascular AUC=
0.802, Respiratory
AUC= 0.736, Hepatic
AUC= 0.655, Renal
AUC= 0.739,
Neurological AUC=
0.727, Coagulation
AUC= 0.684.

Two reviewers
conducted the
search and
differences were
resolved with
inclusion of a third
reviewer. Interobserver agreement
Kappa= 0.94.
No reliability
indicators were
reported for the
models included in
the review.

Model: SOFA

Design: Statistical
performance of the
model was assessed by
examining the reported
discrimination,
calibration, and/or
accuracy.
Studies were included
only if they were in
English, were not
restricted to a specific
diagnosis, and were from
the surgical or medical
ICU populations. Quality
of the studies was
assessed by using a
quality assessment
framework for systematic
reviews of prognostic
studies.

Feasibility

Not reported.

Level of
Evidence8
Level 1:
Systematic
review of
inception cohort
studies.
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Prognostic
Model
Reference
Mortality
Prediction in
Intensive Care
Units with the
Super ICU
Learner
Algorithm
(SICULA): A
PopulationBased Study 30
Model: SICULA,
SAPS II, APACHE
II, SOFA

Veterans Affairs
Intensive Care
Unit Risk
Adjustment

41

Research
Subjects

Study
Purpose/Design

Validity

All patients (n=
24,508) admitted to
an ICU at Beth Israel
Deaconess Medical
Center in Boston
2001-2008. ICUs
included medical,
trauma-surgical,
coronary, cardiac
surgery, and medicalsurgical units.
Patients with greater
than one ICU
admission per
hospital stay were
omitted.
Validation group: 200
randomly selected
ICU patients in a
Paris, France hospital
2013-2014. ICUs
included medical,
surgical, and trauma
units.

Purpose: To determine
whether the SICULA can
provide a new mortality
prediction algorithm for
ICU patients and to
compare its performance
with other validated
scoring systems (SAPS II,
APACHE II, and SOFA).

SOFA Score AUC= 0.71,
SAPS II original version
AUC= 0.78, SAPS II
refitted score AUC=
0.83, APACHE II refitted
score AUC= 0.82, SL1
AUC= 0.85, SL2 AUC=
0.88.
Recorded versus
predicted hospital
mortality (Cox
calibration) SOFA=
0.12, SAPS II original=
0.30, SAPS II refitted=
0.12, APACHE II
refitted= 0.12, SL1=
0.12, SL2= 0.13.
External validation
AUC= 0.94.

All patients (n=
36,240) admitted to
30 ICUs in 15 VA
hospitals July 1999-

Purpose: To further
validate the VA ICU
severity measure by
examining its validity in

Using fixed estimates
from the 1996-1997
data applied to
independent data sets

Design: A machine
learning technique was
used to determine if they
could improve ICU
mortality prediction
compared with
conventional methods
without having to change
their scoring procedures.
Two sets of predictions
were based on the Super
Learner. The first set was
based on SAPS II variables
(SL1). The second set on
the original,
untransformed variables
used in SAPS II and
APACHE II (SL2= SICULA).

Reliability

Feasibility

Level of
Evidence8

Not Reported

Available online for
easy access.
Requires user to
compile various
data-fitting
algorithms and to
specify performance
measures.

Level 2: Large
study with
inception cohort
and randomized
validation
cohort.

Not Reported

Allows for
automated
extraction of data.

Level 2: Large
study with
inception
cohorts.
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Prognostic
Model
Reference

Research
Subjects

Model:
Validation,
Updating,
Recalibration 29

December 2000 using
a stratified sampling
strategy based on
hospital size and
geographic location
comprised cohort 1.
Consecutively
admitted patients
October 2001September 2004
from 62 ICUs in 42 VA
hospitals in six
regions that
participated in a VA
pilot study that
measured and
reported riskadjusted outcomes
comprised cohort 2.
Second or later ICU
admissions during the
same hospitalization,
those lacking arterial
blood gas data, those
transferred to
another hospital at
discharge, and those
that underwent
transplantation were
excluded leaving n=
81,964.

Model: VA ICU

42
Study
Purpose/Design
two larger, diverse
cohorts of VA ICUs, and
comparing its prediction
with the VA National
Surgical Quality
Improvement Plan
(NSQIP= Used by the VA
to assess risk-adjusted
performance including
30-day mortality).
Design: Retrospective
data analysis from two
ICU cohorts. A logistic
regression model was
used to predict hospital
mortality in each cohort.
For cohort 2, the
predictor coefficients
were refit after
expanding the diagnostic
classification and source
of admission variables to
update the model.

Validity

of first ICU admissions,
cohort 1 AUC= 0.8744,
Hosmer-Lemeshow chisquare= 72.5; cohort 2
AUC= 0.88, HosmerLemeshow chi-square=
154.8.
For cohort 1 patients
admitted to the ICU for
a second or third time
during the same
hospitalization, AUC=
0.827 and 0.796,
Hosmer-Lemeshow chisquare= 65.2 and 44.7.
For the validation set of
the updated model,
Brier’s score= 0.060.07.
Comparison of NSQIP
and cohort 1 VA ICU
data (n= 7,411)
revealed VA ICU AUC=
0.83, HosmerLemeshow chi-square=
63.9, SMR= 1.04; NSQIP
AUC= 0.81, HosmerLemeshow chi-square=
92.3, SMR= 1.15.
Updated model AUC=
0.897, HosmerLemeshow chi-square=
79.2.

Reliability

Feasibility

No training is
required.
Requires use of EHR
with data extraction
capabilities.

Level of
Evidence8
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Abstract
Treatments are needed for medical conditions such as Alzheimer’s disease and other
neurocognitive disorders, head trauma, and psychiatric disorders that leave a person
incapacitated, yet individuals with these conditions are often incapable of giving consent
for research. Although there has been a shift in support for surrogate decision making in
research, the decision to consent and agree to continued enrollment of an incapacitated
person in research can place a significant amount of burden on the surrogate decision
maker. The purpose of this integrative review is to discuss and critique the current state
of knowledge related to interventions that can guide researchers in reducing surrogate
burden throughout the research trial, from initial consent to closure of the study and
beyond. 25 articles met inclusion criteria for review. Analysis of the articles revealed six
levels of intervention, from the personal ‘Direct Care of the Surrogate’ to the populationbased ‘Legal/Regulatory’ and provides a framework to assist researchers and other
interested parties when surrogates are relied upon for decision making regarding research
participation.
Keywords: Research consent, Incapacitated research, Surrogate consent, Research
ethics
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Introduction
Medical conditions such as end-stage Alzheimer’s disease and other
neurocognitive disorders, head trauma, and psychiatric disorders that leave a person
incapacitated, or lacking the capacity to physically or mentally make decisions for
themselves (Merriam-Webster, 2017), can be devastating to the affected person and their
family. Current treatments for several of these conditions are only modestly effective in
improving cognitive function and most merely assuage symptoms; therefore, future
research is needed in these areas (Alzheimer’s Association, 2017). However, the very
nature of the illness that renders a person incapacitated is the source of many ethical
issues and can preclude them from consenting to research (Kim, Appelbaum, Jeste, &
Olin, 2004). The literature indicates that persons who are incapacitated should be
excluded from research if the same research can be done with capable participants
(Griffith & Tengnah, 2010; Hoffman & Schwartz, 1998; Kim et al., 2004). However,
advancement in medical treatment can only be made if research can be conducted on
conditions that cause incapacity, and often the enrollment of participants with significant
impairments in expressive language and executive function is required (Karlawish &
Casarett, 2001; Kim et al., 2004). Incapacitated persons are considered the most
vulnerable of all research participants and the researchers are charged with following the
ethical conduct of research and sustaining their moral status while not diminishing the
incapacitated from a level of ‘subjects’ to one of ‘objects’ (Jennings, 2012).
Researchers often utilize a legally authorized representative (LAR) (also referred
to in the literature as research surrogate, proxy, or substitute decision maker) to provide
consent for incapacitated persons to participate in research. The process often appears to
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be straightforward, yet there has been much debate in the literature regarding the use of
surrogate decision makers for research consent (Macciocchi & Alves, 1997; Walters,
2009; Yarborough, 2002). The literature reveals researchers commonly express concerns
that surrogates do not properly understand or are unprepared for their role as surrogate
decision makers (Candilis, Wesley, & Wichman, 1993; Karlawish et al., 2009;
Yarborough, 2002). Additionally, the ethical debate escalates with regard to the
appropriateness of surrogate decision making for incapacitated persons if the research is
considered high risk or nontherapeutic (Warren et al., 1986; Yarborough, 2002). The
challenge for researchers is to develop innovative methods for consent and continued
study enrollment that helps minimize burden for the surrogate decision maker. From
initial surrogate consent, to engagement throughout the research process, researchers
must vigilantly assess for surrogate vulnerability, not just from an ethical stance—but for
the surrogate’s physical, mental and emotional needs as well (Dunn et al., 2013).
Although the Belmont Report, developed decades ago, highlights respect for
persons as one of the basic ethical principles guiding research involving persons who do
not have the capacity to exercise their autonomy (National Commission for the protection
of Human Subjects of Biomedical and Behavioral Research, 1979), there remains to be
limited standards with regard to surrogate-based consent (Office for Human Research
Protections (OHRP), 2009a). There are regulations related to when a surrogate can be
used for consent and who that individual should be if not previously appointed, which is
often governed by states (OHRP, n.d.), but specific interventions that can be used to
support the surrogate during participant enrollment and throughout the research trial are
limited and are provided as ‘recommendations’ only (OHRP, 2009a). The OHRP
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recommends that Institutional Review Boards (IRBs) establish a more variable
risk/benefit ratio as a requirement for approval of studies where a surrogate will be
required for consent (OHRP, 2009a). The OHRP and National Institutes of Health (NIH)
recommend that surrogates be educated on their roles and responsibilities during consent
and throughout the study, receive communication regarding the research participant’s
well-being throughout the study, and inform surrogates of any new information about
risks, benefits, and alternatives related to the study throughout the participant’s
enrollment (NIH, 2009; OHRP, 2009a). These recommendations are developed from
expert opinion, likely based on their experiences. Although expert opinion is valuable,
determining the outcomes of such recommendations is an area warranting further
investigation.
Due to the complexities in surrogate consent for research with incapacitated
persons, this integrative review synthesizes and critiques empirical and theoretical
literature to provide a more comprehensive understanding of the current state of the
science (Whittemore & Knafl, 2005) and provides a framework consisting of six levels of
‘intervention’ to assist researchers and interested parties, such as legal and policy making
groups, with the surrogate consent process. The variables of interest included a review of
interventions available to guide researchers in their decision making surrounding initial
consent and ongoing enrollment for research involving incapacitated persons, in an
attempt to minimize surrogate burden. This review evaluates the extant literature to
determine: among surrogates of incapacitated persons, what are the ethically acceptable
practices that can be utilized by researchers to guide enrollment and supportive
involvement in research related to advancement of treatment?
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Methods
Through an extensive literature review, the variables of interest were identified by
asking the following questions: 1) does the article provide a description of an intervention
that can guide researchers in reducing surrogate burden throughout the research study? 2)
does the article report on testing the intervention and present an outcome?
To accomplish a thorough review of the pertinent literature, a medical librarian
was consulted to identify appropriate databases and search strategies. A systematic search
of five databases was conducted along with a search of the reference list of the retrieved
publications to identify published articles addressing the topic. The database searches
were conducted in PubMed, CINAHL (EBSCOHost), Web of Science, PsychInfo, and
ProQuest Dissertations & Theses. The articles included were limited to those written in
English and addressing an adult population. The search was limited to adults only
because surrogate consent for children is not within the scope of this review. The search
was broken into three concept groups. One group encompassed the terminology used to
describe “competency” (competency, competence, incompetent, incompetency, mental
competence), another covered the terms relevant to “informed consent” (informed
consent, consenting, consent, permission), with the final keyword “research” added.
Medical Subject Headings (MeSH) and equivalent controlled vocabulary and keywords
were utilized in each database as appropriate. The complete search yielded 1096 articles
(Figure 1).
From the total 1096 articles retrieved, a basic review of titles, key words, and/or
abstracts was conducted to assess relatedness to inclusion criteria of United States (US)
and surrogate consent for incapacitated person participation in research. No publication
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date restrictions were imposed as discussion of surrogate consent began in the 1970’s and
our focus was on tracking the direction of discussion as it corresponded with regulation
changes throughout the years related to human protection in research. This initial review
resulted in 476 articles remaining.
Following the initial review, full text articles revealed that 426 of the resulting
articles were not related to surrogate consent for incapacitated person participation in
research or did not occur in the US. The 50 articles that appeared to meet the inclusion
criteria of this review were reviewed in-depth to determine relevance. Although the intent
of the search was to include actual interventions that had been implemented to minimize
surrogate burden throughout the research study, the in-depth review revealed that only
three articles met this criterion. However, many other articles reviewed suggested
interventions based on lessons learned. Because these suggestions were also important to
the knowledge to be gained, they too were included, leaving a total of 25 articles for the
final review.
A matrix (Table 1) was used to extract data from the chosen articles. Findings
from the articles were grouped according to themes identified that were consistent with
the purpose of this review. Specifically, interventions and their outcomes (when
available) were included. This paper is the first known attempt at reviewing interventions
that can guide researchers in reducing surrogate burden throughout the research study.
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Results
All 25 of the articles included addressed at least one intervention for minimizing
surrogate burden at some point during the research trial. Because most articles included
did not directly test interventions, assessing the level of evidence was not applicable;
even those that did test interventions were of mostly mid-level evidence because nonrandomized samples were used for their rather small studies. Included articles spanned
almost 30 years as the process of surrogate involvement continues to evolve with changes
in both healthcare clinical practice and healthcare policy. Surrogates carry a great
responsibility to decide whether or not to consent to initial enrollment and ongoing
engagement for incapacitated persons (Dunn et al., 2013). Therefore, it was of interest to
review interventions aimed at providing the greatest good for the person while
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minimizing the physical and emotional stress experienced by the surrogate. Although few
of the articles discussed actual interventions to improve the surrogate consent process,
many of the articles presented suggested interventions based the study findings, literature
reviews, guideline development/critique, expert opinion, and case studies. In total, six
types of interventions, grouped according to themes, emerged from the review. Arranged
by the level of surrogate involvement, the literature describing each is detailed below. A
common goal of protecting those with diminished autonomy while promoting needed
research involving vulnerable populations was evident in all interventions presented.
1. Direct Care of Surrogate Interventions
Surrogates, whether family, friends or legal representatives of persons who lack
decisional capacity, are asked routinely to make decisions about involvement in clinical
research. Researchers used questionnaire items and open-ended questions to assess how
surrogates for persons with advanced dementia made decisions regarding research
enrollment (Dunn et al., 2013). By answering questions regarding hypothetical clinical
trials, researchers were able to gain knowledge regarding the difficulty (physically,
emotionally, logistically) for surrogates of honoring the wishes of the person while
maintaining their own quality of life. Suggested interventions based on these findings
included incorporating respite care and ongoing education for the surrogates into research
protocols (Dunn et al., 2013).
Caring for individuals who are incapacitated can take a physical and mental toll
on surrogates if they are also the primary caregiver. However, caregivers that enroll
persons in research studies may have less distress from caregiver tasks, perhaps due to
the time allowed to take a break from caregiver duties when study-related activities are
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occurring, although there is no published data to support this inclination (Karlawish &
Casarett, 2001). However, for others, having to drive the participant to a study site may
be more burdensome. If so, it is suggested that the research team could drive to the
location of the person to lessen the travel burden (Karlawish & Casarett, 2001).
2. Advance Directive Interventions
While Advance Directives (AD) may outline end-of-life preferences, these
documents rarely address involvement in clinical research. Currently in the US, specific
regulations regarding advance directives for research are lacking (OHRP, 2009b).
Perhaps this is in part due to varying views regarding ‘advance directives for research’
which is either a special document specifying this preference, or a statement of this
preference within a general advance directive. Those who favor the promotion of advance
directives for research consent ascertain these directives provide a means for a competent
person to exercise his or her right to consent to research participation after their
competence is lost (Buller, 2015).
For states that allow people to designate a surrogate for consent to treatment in the
case of their incapacity, the designation could also be extended to consent to research
(Appelbaum, 2002; Berg, 1996; Fletcher, Dommel, & Cowell, 1985; Kapp, 1994; Miller,
1982; Sachs, 1994; Wendler, Martinez, Fairclough, Sunderland, & Emanuel, 2002). The
most prominent suggestion is for advance directives to validate consent for studies that
have minimal risk with some benefit (Appelbaum, 2002). However, a study that
conducted phone interviews to examine the attitudes of healthy individuals with a family
history of Alzheimer’s disease who had participated in clinical research found that some
individuals would consent to research that offers no potential for medical benefit
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(Wendler et al., 2002). However, others ascertain that incapacitated persons should be
able to participate in research with more than a minimal risk as long as they have an
advance directive indicating their willingness to be enrolled in such studies (Berg, 1996;
Sachs, 1994). Because allowing persons to make specific authorizations within their
advance directive for research would protect autonomy to the greatest extent, researchers
could identify persons who have progressive diseases and encourage them to complete
advance directives for research with specific authorizations while they are still competent
(Miller, 1982). However, others studying dementia assert that advance directives for
research are unlikely to be effective because only a minority of people complete advance
directives for treatment decisions, a likely indicator of how many would contemplate the
unpleasant thought of developing dementia and participating in research (Kim &
Kieburtz, 2006).
Healthy adult individuals with a family history of Alzheimer’s disease that
participated in a study by Wendler et. al. (2002) (n= 246) were assessed regarding their
attitudes surrounding safeguards for research which included incapacitated persons.
Participants indicated advance directives for research should not be automatically
regarded as definitive. Eighty percent of the respondents for the study indicated that it
would be acceptable if their surrogate enrolled them in research that had potential
medical benefits even when their advance directive specified no research participation.
Karlawish et al. (2009) found similar results in a study that explored older adult
participants’ views on granting surrogates leeway to override decisions about research
participation once the person became incapacitated. The results of this study support a
recommendation to grant surrogate leeway over advance consent for research. Noting that
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advance directives may be outdated, an ethics committee position statement from almost
20 years ago also recommends that surrogates should be allowed to refuse or enroll
persons into research studies because they believe their decision is based on the best
interests for the person, even if that decision contradicts with the person’s advance
directive (Sachs, 1998). However, another older working group recommendation from
Maryland’s Policy Initiative argues surrogate consent should not be sufficient when there
is no direct medical benefit but greater than minimal risk (Hoffman & Schwartz, 1998).
3. Enhanced Communication Interventions
Surrogates routinely make decisions without any knowledge of preferences and
may struggle between what they think is best for an incapacitated person versus what
they believe the person wanted (Howe, 2012). Sometimes termed ‘substituted judgment’,
this action is based on essentially extrapolated knowledge of what the ‘impaired’ person’s
values and beliefs would support; some authorities believe this is morally unsound and
care should focus on what is in the person’s best interest (Torke, Alexander, & Lantos,
2008). Even though the opportunity is not always possible, for persons with deteriorating
diseases such as Alzheimer’s, emphasis is placed on communication prior to the person
deteriorating to an incapacitated state (Howe, 2012). Based on public support of surrogate
decision makers, Howe (2012) recommends a psychiatrist taking the initiative to
encourage discussions between individuals and surrogates regarding future research
desires as soon as a person is diagnosed with a deteriorating disease.
Demonstrating the length of time ‘substituted judgment’ has been debated,
Warren et al. (1986) examined the basis for surrogate decision making by questioning
surrogates regarding whether they would consent to the person’s participation in a study
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involving minimal risk. Of the 55 surrogates who believed the person would refuse
enrollment consent, 17 gave consent in opposition to the individual’s indications. Based
on these findings and respect for autonomy, a recommendation was made to have
investigators ask surrogates specifically whether they think the individual would have
consented to the study had the person been competent. Based on a response of “no,” the
recommendation includes disqualifying the person from participation even if the
surrogate is willing to consent.
Surrogates of intensive care unit (ICU) patients often experience stress due to the
critical nature of the patient’s condition; asking them to consent for their loved one’s
participation in research likely adds additional stressors (Shelton, Freeman, Fish,
Bachman, & Richardson, 2015). In an attempt to alleviate some of these stressors,
researchers developed a computer-based education module to see if they could increase
surrogate understanding of the process of informed consent for genomics research. Their
intervention was effective as evidenced by greater understanding of the informed consent
process in the experimental group in comparison to the control group which received a
basic consent form to review (Shelton et al., 2015). The results of this study support the
addition of computer-based education modules to conventional approaches for obtaining
informed consent from surrogates in the ICU.
In addressing the ethical challenges of clinical trials that involve persons with
dementia, Karlawish and Casarett (2001) acknowledged the need to ensure that
individuals and/or their surrogates receive feedback about the results of the research. By
communicating the benefits of their participation, surrogates can feel more comfortable
with their decision to consent to enrollment and ongoing participation. They recommend
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that individuals, and in the case of incapacitated individuals, their surrogates, should
receive feedback about what intervention the individual received and what the overall
results were (Karlawish & Casarett, 2001).
4. Expert Consultant Interventions
A proposal to facilitate surrogate consent suggests that health care institutions
could appoint surrogates or even ‘referees’ to represent the patient’s best interest.
Wendler and Prassad (2001) compared four US and two international guidelines that
proposed safeguards for adults who are unable to consent. Based on their comparison of
points of consensus and differences, they presented six core safeguards for research with
those unable to consent. One safeguard included a recommendation for “consent
monitors” to be utilized when the research involves greater than minimal risk. Consent
monitor use is intended to ensure enrollment is consistent with the individual’s
preferences and interests which can decrease the surrogate’s burden related to decisionmaking (Wendler & Prasad, 2001).
In a study that examined policies and guidelines used by Alzheimer’s disease
researchers pertaining to research involving cognitively impaired individuals, the need
for ethical advice was discovered (Cahill & Wichman, 2000). A recommended
intervention was to include in policy the need for a representative from the bioethics
committee to be available to consult any time in which the investigator, Institutional
Review Board, or surrogate desired ethical consultation (Cahill & Wichman, 2000).
5. Institutional Review Board (IRB) Interventions
The IRB is an institutional body charged with the duty to oversee all aspects of
research that could put an individual at risk especially ‘additional safeguards [for]
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mentally disabled persons … [and] outlines precise requirements for the consent process,
including when consent is provided by an LAR [legally authorized representative]’
(Association for the Accreditation of Human Research Protection Programs (AAHRPP),
2014). Although standard requirements include consent for research prior to accessing
medical records to determine individual eligibility, approaching surrogates for consent
prior to ensuring eligibility may add undue stress. Following completion of a study with
individuals with dementia in the nursing home setting that resulted in a protocol for
informed consent and assent, researchers recommended obtaining an IRB waiver to
access records to assess inclusion-exclusion criteria to ensure only surrogates of eligible
persons were contacted (Batchelor-Aselage, Amella, Zapka, Mueller, & Beck, 2014).
Institutional review boards are charged with analyzing the risks and benefits of
proposed research studies (Kim et al., 2004). One recommendation calls for IRBs to have
a more stringent risk-benefit analysis if there is a proposal that calls for surrogate consent
(Kim et al., 2004). This is an attempt to employ additional safeguards to protect the
interest of incapacitated persons.
The consent process may be too much of an emotional strain for surrogates at the
time research needs to begin in the cases of acute illness leading to an person’s incapacity
(Fost & Robertson, 1980). Institutional review boards have been asked to review research
projects in which investigators asked for omission of consent for research involving
critically ill individuals due to the foreseen stress on the surrogate (Fost & Robertson,
1980). Although the IRB is focused on protection of individuals enrolled in the study,
they did adopt a compromise position in which surrogates would be informed at the time
of admission that the incapacitated person would be entered into a research study, but
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they would not receive explicit study details until later. The intervention was developed
to allow for “deferred consent” in which the investigator was responsible for obtaining
informed consent from the surrogate within 48 hours. In another study, the argument for
“deferred consent” was related more to the desire to uphold the best interest of the
individual when research was available for severe head injury and no surrogate was
readily available (Prentice et al., 1994). The authors suggested that the ability to
participate in limited interventions for severe head injury could bring relief to the
surrogate. For this study, the IRB and US Food and Drug Administration (FDA)
promoted a framework that required documentation of efforts to initially and
continuously contact the surrogate. Once contacted, the surrogate had the ability to
withdraw the incapacitated individual from the study.
Karlawash et al. (2002) surveyed Alzheimer’s disease investigators to determine
how their sites conducted the informed consent process. Although specific information
was not provided, four of the 39 sites reported assessment of surrogate decision-making
capacity in their IRB approved consent procedures. Because of the survey results,
Karlawash et al. (2002) recommended examining whether the materials used to
summarize a study for enrollment recruitment affected surrogate comprehension and
satisfaction with the recruitment and consent process. In cases of complicated research
studies involving high risks, the authors suggested the IRB could require investigators to
take additional steps to ensure surrogate decision maker’s comprehension (Berg, 1996).
For example, they could require employment of a neutral educator to assist the surrogate.
Adults with severe traumatic brain injury (TBI) are likely to exhibit a loss of
decision-making capacity (Pape, Jaffe, Savage, Collins, & Warden, 2004). However,
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unlike other deteriorating diseases, persons with TBI may gain decision-making capacity
following the acute phase of their injury. A study examining the legal and ethical
components of TBI research recognized the need for continued assessment of individual
decision-making capacity following initial research approval by a surrogate (Pape et al.,
2004). Following a review of IRB feedback, weekly consciousness screening and
determination of decision-making capacity were added to research procedures involving
individuals with TBI that required surrogate consent for research (Pape et al., 2004).
Upon return of the individual’s capacity, the surrogate could be relieved of their
decision-making responsibilities.
Kapp (1994) discussed potential surrogate decision-making mechanisms
following an analysis of legal and ethical concerns regarding Alzheimer’s disease. Based
on safeguards needed to protect the vulnerable population of individuals with advanced
Alzheimer’s disease, a recommended intervention of heightened IRB involvement in the
protocol approval process was set forth (Kapp, 1994). Specifically, building in an extra
level of scientific and methodological review to verify an acceptable risk/benefit ratio
was suggested along with additional monitoring if a surrogate was utilized for consent.
6. Legal/Regulatory Interventions
Professional groups interested in promoting research on vulnerable populations
advocate for rules that permit the enrollment of incapacitated patients in appropriate
research missions (Appelbaum, 2002). Appelbaum (2002) suggested a mandate requiring
all states have a statute authorizing surrogate consent to research to decrease the burden
of surrogate decision-making.
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Stocking, Hougham, Baron, and Sachs (2003) sought the opinions of experienced
researchers involved in Alzheimer’s disease research to examine their thoughts on if
additional regulations would provide enhanced protection of research participants. To
their surprise, the results of the survey revealed that half of the participants did not
perceive that having a standardized surrogate selection process (when not indicated by
the individual prior to their incapacitated state) would enhance participant protection.
However, since nearly an equal number of participants perceived a standardized surrogate
as a means of increased protection, the study researchers hypothesized that the mixed
feedback was a result of possible added workload that would result from utilization of the
regulation.
Synthesis
This review covers almost four decades of studies and reviews that make
recommendations about six lenses through which the consenting and continued
enrollment processes for incapacitated persons could be viewed. Two are focused on the
personal level – direct care of the surrogate; eleven are focused on advance directives and
how they might relate to research participation; four address the process of enhanced
communication with the surrogate; two advocate for the role of experts; eight are
centered on the role of the IRB for the protection of human ‘subjects’; and finally, two
are centered on proposed legal/regulatory changes.
The limitation seen throughout the literature is that many of these interventions
are recommendations only; few have actually been tested. Additionally, there are a few
recommendations from regulators for supporting surrogates (Office for Human Research
Protections, 2009a) but the results of this review further concede that few outcomes of
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these recommendations have been reported. Therefore, do we really know the
interventions being recommended are effective at supporting surrogates throughout the
research trial? Because researchers are all trained on the principles of human subject
protection and the surrogate is an extension of the ‘subject,’ it is likely that researchers
are already following some of these recommendations but not reporting outcomes related
to their interventions.
Advance directive interventions are complicated by the fact that relatively few
people complete advance directives. Although the rate of completion has increased over
the last decade, more current estimates still indicate that less than 30 percent of
Americans have advance directives (Black, 2010). Furthermore, even when directives are
present, they contain little information regarding the desires of the person to participate in
research (Kim et al., 2013). These findings are coupled with evidence that even
high-quality directives do not improve accuracy in the surrogates’ ability to predict the
preferences of the incapacitated person (Ditto et al., 2001; Kim et al., 2013).
Issues may not be related to the effectiveness of surrogate consent but may be
rooted in the problems with inconsistencies in the consent process and ongoing
engagement to minimize surrogate burden throughout the research trial. The quality and
support given to the surrogate, rather than the risk of the study, emerges as the ethically
fundamental consideration in deciding whether to enroll incapacitated persons in research
(Yarborough, 2002).
Recommendations for Research
Most of the articles discovered in this review are greater than a decade old, with
some as old as almost four decades. Given the emerging research in areas involving those
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with potentially diminished capacity, the need to revisit ways in which we can support
surrogates during research trials involving incapacitated individuals is needed. For
example, as life expectancy has expanded, new types of gene-altering techniques (i.e.
CRISPR/Cas 9) are being studied in those with neurodegenerative disorders (Yan, Tu, Li,
& Li, 2017).
One of the primary principles in the Belmont Report includes beneficence in
which persons should be protected from harm and efforts to secure their well-being are
made (Biomedical & Behavioral Research MD., 1978). While great efforts have been
made to ensure this ethical principle for individuals eligible for research participation is
respected, it behooves us to treat surrogate decision-makers in the same respect by
securing their well-being through interventions accounted for in research protocols. There
is a need to identify effective interventions to minimize surrogate burden; this review is
only a starting point. The interventions found through this review to help minimize
surrogate burden provide a framework for researchers to consider when designing studies
that likely involve surrogate decision-making, but the interventions need to be further
tested and the framework further developed.
Initiatives towards this goal would be a noteworthy contribution to the evidence
that will be necessary to expand opportunities for the participation of incapacitated
persons in research. Expanding research opportunities for persons with end stage
Alzheimer’s disease and other neurocognitive disorders, head trauma, severe stroke, and
psychiatric disorders has the potential to make scientific progress in the prevention and
treatment of these diseases.
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Table 1. Summary of Findings
Author, Date, Title

Purpose

Study Design

Intervention
Type

Intervention

Appelbaum, P. S.
(2002). Involving
decisionally impaired
subjects in research:
The need for
legislation. American
Journal of Geriatric
Psychiatry, 10(2), 120124.

To provide a position N/A
statement regarding a
need for legislation
for involving
decisionally impaired
subjects in research.

Advance Directive Suggested: For states with
statutes authorizing surrogate
Legal/Regulatory consent to treatment, the power
they convey should be extended
to research consent.
Suggested: States without
statutes authorizing surrogate
consent to research that presents
minimal risk with some benefit
should develop them.

Batchelor-Aselage, M.,
Amella, E., Zapka, J.,
Mueller, M., & Beck,
C. (2014). Research
with dementia patients
in the nursing home
setting: A protocol for
informed consent and
assent. IRB: Ethics and
Human Research,
36(2), 14-20.

To describe the
implementation of a
consent protocol that
can be used when
recruiting
participants that are
decisionally
incapacitated.

Institutional
Review Board

N/A

Level of Evidence
(OCEBM Levels of
Evidence, 2011)
N/A: Position
Statement

Suggested: Obtain IRB
N/A: Protocol
approval to access medical
Development
records for patients to
determine recruitment
eligibility prior to contacting
the representatives of persons
with dementia. This limits
contacting surrogates of patients
that are not eligible.
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Author, Date, Title

Purpose

Study Design

Berg, J. W. (1996).
Legal and ethical
complexities of consent
with cognitively
impaired research
subjects: Proposed
guidelines. Journal of
Law, Medicine &
Ethics, 24(1), 18-35.

To examine the
historical evolution
of constraints on
human
experimentation and
explore the contours
of surrogate decision
making.

Cahill, M., &
Wichman, A. (2000).
Research involving
persons with cognitive
impairments: Results
of a survey of
Alzheimer disease

To assess policies or N/A
guidelines used by
Alzheimer’s Disease
Centers with regard
to research involving
cognitively impaired
subjects.

N/A

Intervention
Type

Intervention

Advance Directive Suggested: Allow competent
subjects to consent in advance
Institutional
and designate a surrogate for
Review Board
future research participation
purposes once the subject is no
longer competent.
Suggested: Allow incompetent
subjects to enroll in greater than
minimal risk studies as long as
their advance consent indicated
this designation. However,
allow the surrogate to
withdrawal the subject from the
research if they believe the
subject would have withdrawn
themselves.
Surrogate: In cases of
complicated research studies,
the IRB might require
investigators to employ neutral
educators to ensure surrogate
comprehension of the study.
Expert Consultant

Level of Evidence
(OCEBM Levels of
Evidence, 2011)
N/A: Guideline
Proposal

Suggested: A representative
N/A:
from the bioethics committee
Policy/Guideline
should be available to consult in Review
any situation in which the
principle investigator, IRB, or
surrogate desires further ethical
advice.
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Author, Date, Title

Purpose

Study Design

Intervention
Type

Intervention

Level of Evidence
(OCEBM Levels of
Evidence, 2011)

research centers in the
United States.
Alzheimer Disease and
Associated Disorders,
14(1), 2-27.
Dunn, L. B., Fisher, S.
R., Hantke, M.,
Appelbaum, P. S.,
Dohan, D., Young, J.
P., & Roberts, L. W.
(2013). “Thinking
about it for somebody
else”: Alzheimer’s
disease research and
proxy decision makers’
translation of ethical
principles into practice.
American Journal of
Geriatric Psychiatry,
21(4), 337-345.

To examine whether
and to what degree
surrogates
differentiate between
consenting dementia
patients for research
based on “substituted
judgment” or based
on the patient’s best
interests.

Interviewed 40 Direct Care of
surrogate
Surrogate
decision
makers to
assess their
different
approaches to
decision
making for the
patient.

Suggested: Offer services to
help make the research
participation more convenient
and rewarding for the
participant and surrogate.
Services include respite care,
transportation, education, etc.
Incorporate these services into
the research protocol.

Level 3: Nonrandom Sample

Fletcher, J. C.,
Dommel, F. W., &
Cowell, D. D. (1985).
A trial policy for the
intramural programs of
the National Institutes
of Health: Consent to
research with impaired

Describe a trial
policy for the consent
process with
impaired human
subjects for the
intramural research
programs of the

Trial of a
Advance Directive
policy for the
intramural
research of the
NIH.

Actual: Policy that incorporates N/A: Policy
Durable Power of Attorney
Development
(DPA) appointment by a
prospective research subject,
determination of when the DPA
should be used, and DPA ability
to approve the incapable
subject’s enrollment into a
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Author, Date, Title

Purpose

Study Design

Intervention
Type

Intervention

Level of Evidence
(OCEBM Levels of
Evidence, 2011)

human subjects. IRB:
Ethics and Human
Research, 7(6), 1-6.

National Institute of
Health (NIH).

study with no more than
minimal risk.

Fost, N., & Robertson,
J. (1980). Deferring
consent with
incompetent patients in
an intensive care unit.
IRB: Ethics and
Human Research, 2(7),
5-6.

To describe instances N/A
when “deferred
consent” may be an
applicable approach
for enrolling
incompetent patients
in the intensive care
unit (ICU) into
research studies.

Institutional
Review Board

Hoffmann, D. E., &
Schwartz, J. (1998).
Proxy consent to
participation of the
decisionally impaired
in medical research -Maryland’s policy
initiative. Journal of
Health Care Law &
Policy, 1(1), 123-153.

To provide working N/A
group
recommendations
regarding surrogate
consent for
participation of the
decisionally impaired
in medical research.

Advance Directive Suggested: In the absence of
direct medical benefit with
increased risk, relying on the
surrogate’s “substituted
judgment” should not be
enough to approve enrollment
of a decisionally impaired
subject in research.

N/A: Policy
Development

Howe, E. (2012).
Informed consent,
participation in
research, and the
Alzheimer’s patient.

To discuss the ethical N/A
issues of informed
consent and
participation in

Enhanced
Communication

N/A: Expert
Commentary

Suggested: Allow for “deferred N/A: Case Study
consent” for research involving
incompetent subjects in the
ICU. Surrogates would be
notified that an experimental
procedure was being used but
requests for surrogate consent
would be deferred until 48
hours after the start of the study.

Suggested: Encourage patients
with Alzheimer’s disease to
discuss their future wishes as
fully as possible with their
chosen surrogate decision
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Author, Date, Title

Purpose

Study Design

Intervention
Type

Innovations in Clinical research involving
Neuroscience, 9(5-6), Alzheimer’s patients.
47-51.

Intervention

Level of Evidence
(OCEBM Levels of
Evidence, 2011)

maker before they enter a
research study.

Kapp, M. B. (1994).
Proxy decision making
in Alzheimer disease
research: Durable
powers of attorney,
guardianship, and other
alternatives. Alzheimer
Disease and Associated
Disorders, 8(4), 28-37.

To discuss potential
surrogate decisionmaking mechanisms
regarding research
participation in light
of ethical and legal
concerns.

N/A

Karlawish, J. H., &
Casarett, D. (2001).
Addressing the ethical
challenges of clinical
trials that involve
patients with dementia.
Journal of Geriatric

To determine
N/A
whether and how
patients’ cognitive
impairments and the
caregiving
experience impact on
their decision making

Advance Directive Suggested: Heightened IRB
N/A: Framework
involvement for research
Development
Institutional
protocols contemplating the use
Review Board
of dementia patients. This
would include an extra level of
review to verify an acceptable
risk/benefit ratio.
Suggested: Encourage
individuals in early stages of
Alzheimer’s disease (or before)
to complete an advance
directive where they indicate a
surrogate to make future
research participation decisions
for them. The individuals
should communicate their
values and preferences to their
chosen surrogate.
Direct Care of
Surrogate
Enhanced
Communication

Suggested: Minimize travel to
N/A: Literature
the study site by having the
Review
research team make home
visits.
Suggested: Research protocol to
include ensuring that the subject
(and/or surrogate) receive
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Author, Date, Title

Purpose

Study Design

Intervention
Type

Psychiatry and
Neurology, 14, 222228.

and what kinds of
research justify
research risks.

Karlawish, J. H.,
Knopman, D., Clark,
C. M., Morris, J. C.,
Marson, D.,
Whitehouse, P. J., &
Kawas, C. H (2002).
Informed consent for
Alzheimer’s disease
clinical trials: A survey
of clinical
investigators. IRB:
Ethics and Human
Research, 24(5), 1-5.

To better understand
the process of
informed consent for
Alzheimer’s disease
(AD) clinical trials.

Surveyed 39
AD clinical
research sites.

Karlawish, J.,
Rubright, J., Casarett,
D., Cary, M., Have, T.
T., & Sankar, P.
(2009). Older adults’
attitudes toward
enrollment of noncompetent subjects
participating in
Alzheimer’s research.
American Journal of

To explore older
persons’ attitudes
about enrolling noncompetent patients
with Alzheimer’s
disease in research
without presenting
any potential benefit
to participants.

Interviewed
Advance Directive
538 subjects
greater than 65
years old to
assess their
perception of
research with
non-competent
patients.

Intervention

Level of Evidence
(OCEBM Levels of
Evidence, 2011)

feedback about the intervention
that the subject received and the
results of the study.
Institutional
Review Board

Suggested: Assess caregiver
Level 3: Nondecision-making capacity.
random Sample
Already used at 4 sites that
responded to survey.
Suggested: Test whether
materials used to describe study
for enrollment purposes
enhance caregiver
comprehension and satisfaction
with recruitment and informed
consent process.

Suggested: Grant surrogate
Level 3: Nonleeway over advance consent.
random Sample
This includes enrollment of
non-competent patients in
research on the patient’s disease
even if that research will not
benefit the study participant’s
health but might benefit others
instead.
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Author, Date, Title

Purpose

Study Design

Intervention
Type

Intervention

Level of Evidence
(OCEBM Levels of
Evidence, 2011)

Psychiatry, 166(2),
182-188.
Kim, S. Y.,
Appelbaum, P. S.,
Jeste, D. V., & Olin, J.
T. (2004). Proxy and
surrogate consent in
geriatric
neuropsychiatric
research: Update and
recommendations.
American Journal of
Psychiatry, 161(5),
797-806.

To discuss, critique, N/A
and provide
recommendations for
clear legal and
regulatory policy for
research involving
decisionally
incapable adults.

Institutional
Review Board

Kim, S. Y., &
Kieburtz, K. (2006).
Appointing a proxy for
research consent after
one develops dementia.
Neurology, 66, 12981299.

To review the current N/A
literature related to
appointing a
surrogate for research
consent for patients
with dementia.

Advance Directive Suggested: Consider
alternatives to relying on
advance directives to indicate
research preferences or
designate a surrogate because
only a minority of persons
complete an advance directive
even for treatment decisions.

Miller, B. L. (1982).
Autonomy and Proxy
Consent. IRB: Ethics
and Human Research,
4(10), 1-8.

To determine
whether, and if so to
what extent,
surrogate consent is
consistent with the
right to autonomy.

Advance Directive Suggested: Advance directives N/A: Concept
for research purposes should be Analysis
used by those with capacity to
express their research
participation preferences before
they lose decisional capacity.

N/A

Suggested: For studies that
N/A: Policy
involve no benefit for the
Development
subject, a more conservative
risk-benefit analysis is required.
Suggested: IRBs have a more
stringent risk-benefit analysis if
there is a proposal that calls for
surrogate consent.

N/A: Literature
Review
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Author, Date, Title

Purpose

Study Design

Intervention
Type

Intervention

Level of Evidence
(OCEBM Levels of
Evidence, 2011)
N/A: Protocol
Analysis

Pape, T. L., Jaffe, N.
O., Savage, T., Collins,
E., & Warden, D.
(2004). Unresolved
legal and ethical issues
in research of adults
with severe traumatic
brain injury: Analysis
of a ongoing protocol.
Journal of
Rehabilitation
Research &
Development, 41(2),
155-174.

To identify, define,
N/A
and clarify the
unresolved legal and
ethical issues
regarding research
involving adults with
traumatic brain injury
(TBI).

Institutional
Review Board

Actual: Procedure for defining
and determining lack of
capacity and return to capacity
was incorporated into research
procedures involving subjects
with TBI. Weekly
“consciousness screening” and
“determination of decisionmaking capacity” placed in
consenting procedures of
research study.

Prentice, E. D.,
Antonson, L.,
Leibrock, L. G.,
Prabhu, V. C., Kelso,
T. K., & Sears, T. D.
(1994). An update on
the PEG-SOD study
involving incompetent
subjects: FDA permits
an exception to
informed consent
requirements. IRB:
Ethics and Human
Research, 16(1/2), 1618.

To describe the IRB
approval algorithm
for use in a
randomized control
trial to investigate a
treatment for severe
closed head injury.

Institutional
Review Board

Suggested: Allow for “deferred N/A: Protocol
consent” for research involving Development
subjects with severe closed
head injury. Algorithm includes
attempts to identify the patient,
contact their surrogate, obtain
retrospective consent from the
surrogate, withdrawal from
study if surrogate refuses to
consent.

N/A
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Author, Date, Title

Purpose

Study Design

Sachs, G. A. (1994).
Advance consent for
dementia research.
Alzheimer Disease and
Associated Disorders,
8(4), 19-27.

Examine dementia
research issues and
the advance consent
model.

N/A

Sachs, G. A. (1998).
Informed consent for
research on human
subjects with dementia:
AGS ethics committee
position statement.
Journal of American
Geriatric Society,
46(10), 1308-1310.

To provide position
statements regarding
informed consent for
dementia research.

N/A

Intervention
Type

Intervention

Level of Evidence
(OCEBM Levels of
Evidence, 2011)
Advance Directive Suggested: Designation of
N/A: Model
surrogate for research decision- Analysis
making could be a part of the
advance consent process, with
or without specific guidelines
regarding what decisions that
surrogate should later make.
Suggested: Advance consent for
research could be in the form of
a written document or
conversations with an
individual. Should not require a
formal advance directive for
dementia research to take place.
Advance Directive Suggested: Advance directives N/A: Position
for research purposes should be Statement
used by those with capacity to
express their research
participation preferences before
they lose decisional capacity.
These preferences should be
respected in the future.
Suggested: Limit research that
does not provide direct benefit
to the subject but exposes them
to more than minimal risk to
those subjects with an advance
directive indicating their
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Author, Date, Title

Purpose

Study Design

Intervention
Type

Shelton, A.K.,
Freeman, B.D., Fish,
A.F., Bachman, J.A., &
Richardson, L.I.
(2015). A computerbased intervention to
enhance surrogates’
informed consent for
genomics research.
American Journal of
Critical Care, 24(2),
148-155.

To examine the
effectiveness of a
computer-based
education module on
surrogates’
understanding of the
informed consent
process for genomics
research.

Provided an
Enhanced
education
Communication
module to
experimental
group (n= 65),
then compared
their test
results on
informed
consent with
control group
(n= 69).

Stocking, C. B.,
Hougham, G. W.,
Baron, A. R., & Sachs,
G. A. (2003). Are the
rules for research with
subjects with dementia

To examine the
recommended
additional protections
for persons with
dementia included in
clinical research.

Surveyed 38
research
authors
regarding
consent

Legal/Regulatory

Intervention

Level of Evidence
(OCEBM Levels of
Evidence, 2011)

willingness to be enrolled in
such studies.
Suggested: Allow surrogates to
refuse to enroll subjects or to
withdraw a subject from an
ongoing study because they
believe the study is not in the
best interests of the subject,
even if that decision goes
against the subject’s advance
directive.
Actual: Add computer-based
Level 2:
education modules to
Randomized Study
conventional approaches for
obtaining informed consent
from surrogates in the ICU.
Module in this study included
information on the essential
elements of informed consent,
surrogate consent, research in
general, and genomics research.

Suggested: Having a
Level 3: Nonstandardized surrogate selection random Sample
process when not indicated by
the patient prior to their
incapacitated state. Survey
revealed roughly half of
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Author, Date, Title

Purpose

changing? Neurology,
61, 1649-1651.

Study Design

Intervention
Type

Intervention

Level of Evidence
(OCEBM Levels of
Evidence, 2011)

procedures and
trial risks.

participants perceived a
standardized surrogate as a
means of increased patient
protection - Study researchers
hypothesize the mixed feedback
was a result of potential added
workload that would result.
Suggested: Patient should be
Level 3: Nonexcluded from study
random Sample
participation if the surrogate
answers “no” when asked
whether they think the patient
would consent to the study if he
or she were competent, even if
the surrogate is willing to
consent.

Warren, J. W., Sobal,
J., Tenney, J. H.,
Hoopes, J. M.,
Damrom, D., ……
Muncie, H. L. (1986).
Informed consent by
proxy: An issue in
research with elderly
patients. The New
England Journal of
Medicine, 315(18),
1124-1128.

To study the
decisions of
surrogates regarding
whether to permit
incompetent patient’s
participation in a
study involving
minimal risk.

Interviewed
Enhanced
151 surrogates Communication
for their
perspective
using a
standardized
questionnaire

Wendler, D., Martinez,
R. A., Fairclough, D.,
Sunderland, T., &
Emanuel, E. (2002).
Views of potential
subjects towards
proposed regulations
for clinical research
with adults unable to

To assess healthy
individuals’ attitudes
toward proposed
safeguards related to
the consent process
for research with
adults unable to
consent.

Interviewed
246
individuals to
assess their
attitudes
towards
proposed
safeguards

Advance Directive Suggested: Incorporate
Level 3: Nonstatements about individuals’
random Sample
research preferences on clinical
advance directives. This may
also prompt individuals to
discuss their preferences with
their families.
Suggested: Allow surrogates to
override the preferences
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Author, Date, Title

Purpose

Study Design

Intervention
Type

consent. American
Journal of Psychiatry,
159(4), 585-591.

Wendler, D., &
Prasad, K. (2001).
Core safeguards for
clinical research with
adults who are unable
to consent. Annals of
Internal Medicine,
135(7), 514-523.

Intervention

Level of Evidence
(OCEBM Levels of
Evidence, 2011)

specified in an advance
directive regarding research if it
is in the best interest of the
patient.
To compare
safeguards for
clinical research
with adults who
unable to consent to
compare points of
consensus and
differences.

N/A

Expert Consultant

Suggested: Utilize “consent
monitors” when the research
involves greater than minimal
risk. Consent monitor use is
intended to ensure enrollment
is consistent with the patient’s
preferences and interests.

N/A: Guidelines
Comparison
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Abstract

Background- Uncertainties in prognosis remain a barrier to end-of-life (EOL)
communication in the adult intensive care unit (ICU). Providers often base assessments
of prognosis on experience rather than on objective measures, and may be unaware of
patients’ wishes regarding EOL care. These factors may lead to prolonged dying and
over-use of intensive resources. Mechanisms for increasing the accuracy and timeliness
of EOL care goal communication are needed.
Objective- This study evaluated 1) the acceptability and feasibility of providers’ use of
patient mortality prediction scores as part of routine practice, and 2) providers’ intentions
to change practice, related to goals-of-care communication, as a result of awareness of
the scores.

Method- An explanatory mixed-methods approach was used. Using the Sequential Organ
Failure Assessment (SOFA), mortality prediction scores were provided to ICU providers
(n=12) for patients admitted (n=145) under their care for ten consecutive days.
Subsequently, the providers completed a questionnaire regarding the acceptability and
feasibility of using the scores as part of their workflow and practice. Follow-up
interviews (n= 7) were used to further understand questionnaire responses and gain
insight into providers’ perceptions regarding EOL practice changes as a result of having
the scores readily available.

Results- Overall, use of mortality risk prediction scores as part of routine workflow and
practice was found to be acceptable and feasible – providers agreed to participate, patient
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mortality risk were evaluated, and overall, participants found use of daily mortality
prediction scores possible in their setting. However, there was some disagreement related
to the use of SOFA scores as an effective way for determining patient mortality risk.
Based on themes that emerged from interviews, providers with limited ICU experience
were eager and accepting of the mortality risk scores while those with vast experience
found the scores to be an adjunct to their own intuition; though all acknowledged the
benefit of looking at daily scores or ‘trends’. The most substantial of all themes identified
was the need to consider SOFA scores in relation to patient context; a number alone
should not determine mortality risk and whether a goals-of-care conversation needs to
occur.

Discussion- Overall, participants indicated that using mortality prediction scores as part
of their daily workflow was acceptable and feasible. Use of SOFA scores for potentially
increasing EOL goals-of-care conversations appears to be most beneficial for providers
with limited ICU experience. Large-scale studies are needed to determine the effect of
using mortality risk predictions on patient EOL outcomes.

Key Words: Poor Prognosis, Mortality Risk, Intensive Care, End-of-Life, Goals of Care,
Severity of Illness, SOFA
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Introduction

While healthcare teams recognize that profoundly ill patients in adult intensive
care units (ICUs) may die, many families are caught by surprise when their loved one
dies in a setting with the most advanced technology and intense care available. ICU
deaths account for about 20% of patient deaths in US hospitals and this rate is increasing 1
due in part to deficiencies in end-of-life (EOL) care communication that can compromise
quality of EOL care2 and increase resource utilization.3,4 Previous studies suggest that
communication about EOL goals-of-care is infrequent among healthcare providers,
patients, and families; often occurs late in the course of illness5,6; and relies on family
members to act as patient surrogates in discussions.7 Furthermore, despite advances in
healthcare quality, family members remain more dissatisfied with communication in the
ICU than with other aspects of care.8,9
Increased severity of illness (SOI) scores are associated with a significant increase
in the relative risk of hospital death.10 Family meetings about EOL care can improve
family satisfaction with the EOL experience;11 however, uncertainties in prognosis (e.g.,
SOI) are a barrier to EOL communication in the ICU.12 SOI mortality risk prediction
scores are not routinely calculated and there is little research examining their use for
improving EOL goals-of-care communication. There are multiple valid and reliable SOI
scoring systems that are available for predicting ICU mortality,13 but there is no clear
consensus about how or when to use them in patient care and provider-patient/family
communication.
Unfortunately, no evidence-based standard of care exists for EOL goals-of-care
communication in adult ICUs. Mechanisms for increasing the timeliness and frequency of
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discussions about EOL goals-of-care are needed.14,15 As an initial step in addressing this
gap, this study aimed to determine the acceptability, feasibility, and potential impact of
using SOI mortality risk prediction scores for initiating EOL goals-of-care
communication in the adult ICU.
The specific aims of this study were to:
1. Evaluate four valid SOI instruments to determine which instrument, or combination of
instruments, was the best fit for the study site, given providers’ perceived feasibility of
use.
2. Evaluate the acceptability and feasibility of having providers use SOI mortality
prediction scores for their patients as part of routine workflow and practice.
3. Evaluate providers’ intentions to change their practice related to goals-of-care
communication with patients and/or their families as a result of awareness of SOI
mortality prediction scores.
Methods
This study used a mixed-methods explanatory design and took place in a medicalrespiratory ICU (MRICU) at a large academic medical center in Richmond, Virginia.
Patients are admitted to this unit for acute illnesses but commonly exhibit chronic
medical conditions as well. Two medical teams provide patient care, each comprised of
an attending physician, a fellow physician, and a mix of interns, residents, acute care
nurse practitioners (ACNPs), and physician assistants (PAs). These teams provide care
for patients throughout their ICU stay, or until the end of the provider’s assigned time in
the MRICU. This study was approved by the Institutional Review Board at Virginia
Commonwealth University and the Medical University of South Carolina.
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To address Aim 1, attending physicians, fellow physicians, ACNPs, and PAs
working in the MRICU were recruited (target N=6) for a focus group via email as they
are expert providers responsible for medical care of patients admitted to the unit. Based
upon an integrative review completed by the principal investigator 13 (PI) and
implementation feasibility within the study setting, four SOI scoring systems (MPM III,
APACHE IV, SOFA, SAPS III) were presented to the focus group participants. The PI
assumed the moderator role to keep the flow of the conversation on target. 16 Following a
brief introduction about the purpose of the group, participants were asked to discuss
perceived feasibility of use for each SOI system. Based on discussion among the
participants, the PI then requested consensus on the SOI system of choice. Participants
were also asked to complete a demographic form in Research Electronic Data Capture
(REDCap). Descriptive statistics were used to analyze the demographic data.
To address Aim 2, an explanatory mixed-methods approach consisting of a
quantitative questionnaire (target N=12) and a qualitative follow-up interview (target
N=6) were used to determine if providers could feasibly use SOI mortality prediction
scores as part of their routine in the ICU and evaluate their perceptions of acceptability,
feasibility, and potential impact of using the SOI scores. All MRICU fellows, residents,
and intern physicians, as well as all ACNPs and PAs, were recruited on an ongoing basis
via email and face-to-face for this portion of the study; attending physicians were
excluded due to their short length of rotations in the ICU. The PI or research assistant
(RA) calculated mortality risk percentages for MRICU patients admitted under the care
of study participants for ten consecutive days, using the free web-based calculator
available to the public. To ensure consistency and congruency with the chosen system’s
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published protocol, the PI developed a user’s manual for the PI and RA to use. The PI
and RA reviewed a random selection of 25% of each other’s calculations to examine
inter-rater reliability. Calculated scores were limited to three days per patient for
feasibility purposes. Mortality risk percentages were shared with participants on a card
each morning prior to team rounding. Laminated reference cards were provided during
study enrollment for interpretation of the scores. Following the ten-day period,
participants received a link to a REDCap questionnaire (Figure 1) asking about
acceptability and feasibility of using the SOI mortality risk prediction scores as part of
their workflow and practice.17 Results of the questionnaire were retrieved from REDCap
as descriptive statistics. Additionally, participants who did not also participate in the
focus group were asked to complete the same demographic form in REDCap.
To further explain the acceptability and feasibility questionnaire results and to
address Aim 3, all participants who received scores and completed a questionnaire were
contacted approximately one week later asking for their participation in a follow-up
interview. Those agreeing to participate were scheduled for face-to-face interviews with
the PI in a private setting using open-ended questions. Although specific topics were
covered during the interview (Figure 2), the PI allowed the interview to move freely from
topic to topic, allowing the participant’s cues to determine the flow. 18 Each interview was
voice recorded digitally and transcribed verbatim. A qualitative descriptive approach was
used to analyze the interview data.19,20 To accomplish this, a fluent process occurred
wherein transcripts were reviewed following every 2-3 interviews; they were read
repeatedly to achieve immersion, exact words that captured key thoughts were
highlighted, notes of impressions were made in the margins, and key themes were
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identified that emerged from the notes. As these themes emerged, the PI asked for
confirmation from subsequent participants. The resulting themes from all transcripts were
defined and exemplars were identified. To ensure the resulting themes were credible, the
PI discussed the findings with experts who were familiar with the subject under study.
Lastly, final themes and exemplars were examined to help explain the results of the
acceptability and feasibility questionnaire.
Results
Participant Characteristics
The age of all participants combined ranged from 26-51, with a majority being
female (60%) and white (93%). However, there was greater diversity in discipline of
practice with a total of four ACNPs, one PA, and ten physicians (four interns, two
residents, two fellows, and two attendings) participating (total n=15). Additionally, there
was diversity in years of practice in the ICU setting and previous EOL experience (Table
1).
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Table 1. Study Participant Demographics
Variable

Statistic

Gender
Female
Male

60% (9/15)
40% (6/15)

Race
American Indian or Alaska Native
Asian
Black or African American
Native Hawaiian or Other Pacific Islander
White
Other

0%
6.7% (1/15)
0%
0%
93.3% (14/15)
0%

Health Discipline
Acute Care Nurse Practitioner
Physician Assistant
Physician
Intern
Resident
Fellow
Attending

26.7% (4/15)
6.7% (1/15)
66.7% (10/15)
40% (4/10)
20% (2/10)
20% (2/10)
20% (2/10)

Years of Practice in an ICU Setting
Less than one year
One year
Two years
Three years
Four years
Greater than four years

26.7% (4/15)
0% (0/15)
6.7% (1/15)
26.7% (4/15)
13.3% (2/15)
26.7% (4/15)

Previous Experience with EOL
None
Personal (i.e. loss of someone close to you)
Professional
Coursework on EOL care
Hands-on experience with patients during their EOL

6.7% (1/15)
60% (9/15)
73.3% (11/15)
45.5% (5/11)
81.8% (9/11)

Focus Group
Two ACNPs, two attending physicians, and one fellow physician participated in
the exploratory SOI instrument selection focus group (n=5); an additional ACNP was
unable to attend due to scheduling conflicts. Following discussion, the Sequential Organ
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Failure Assessment (SOFA) was chosen by the group as the most feasible to use for the
study site given its free and easy online access, limited number of variables required,
ability to provide admission and daily scores, and increasing use (and therefore,
recognition among providers) due to its role in the updated sepsis guidelines. 21 SOFA
assigns 1-4 points to the following organ systems depending on the level of organ
dysfunction: circulatory, respiratory, renal, hematologic, hepatic, and central nervous
system.22 Data required for the calculation are typically collected upon ICU admission,
and daily thereafter throughout the ICU stay, with the most abnormal values for each day
being used for scoring.23
Acceptability and Feasibility Questionnaire
Two of the ACNPs who participated in the focus group also participated in the
second phase of the study. These ACNPs, along with two additional ACNPs, one PA,
four interns, two residents, and one fellow physician (total n=12) received SOI mortality
risk prediction scores (total n= 145) for ten days for patients admitted under their care.
Scores were calculated for 70 patients total with an average of 2.1 daily scores provided
per patient; some patients were transferred out of the unit or died which prohibited a full
three days of calculations. Additionally, some providers simultaneously enrolled in the
study cared for the same patients allowing for concurrent score calculations. Patient
census was higher than expected during the study period, which enabled participants to
have greater exposure to the SOI scores than originally expected. On average,
participants received scores for 2.6 patients per day. When reviewing a random sample of
each other’s calculations, there were two SOFA scores in which the PI and RA had
conflicting calculations; these were resolved by a simultaneous review of the various
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SOFA variables. Questionnaire data (Figure 3) revealed that overall, participants found
use of SOI mortality prediction scores for their patients as part of routine workflow and
practice to be acceptable and feasible. However, there was some disagreement,
particularly related to the use of the scores as an effective way for determining patient
mortality risk that warranted exploration.
The PI and RA spent an average of 12 minutes per patient to calculate SOFA
scores using the online calculator available (http://clincalc.com/icumortality/sofa.aspx);
with the additional time required to check 25% of each other’s calculations, the total time
spent by the PI and RA in calculating scores was approximately 20 hours. Additionally,
calculations required early arrival to the unit so scores could be calculated prior to team
rounding each morning.
Face-to-Face Interviews
Seven of twelve participants who received daily SOI scores participated in a
follow-up interview. A summary of participant responses follows, organized according to
main themes that correspond with the purpose of this study, then divided into subthemes,
identified throughout the transcriptions:
Effects on clinical decision-making
Context. The most substantial of all themes identified, participants reported the
need to consider SOFA scores in relation to patient context. Respondents suggested that a
number alone should not determine mortality risk and whether a goals-of-care
conversation should occur, as there could be contextual issues related to the score being
elevated. The following example illustrates this theme:

EFFECT STUDY

89

There was a patient, for example, that was kind of middle of the road, so probably
around a 50% mortality risk, but they had a procedure done and they were
intubated and were put on 100% [oxygen on the ventilator]. They were bronched
or something.
Level of experience. Participants with limited ICU experience (less than one
year), either personally or professionally, were eager and accepting of SOI mortality risk
prediction scores provided for them. This was due to the ability of SOFA scores to detect
nuances that they did not always see in the clinical picture alone and because they
experienced instances where SOFA scores they received that differed from their
subjective assessment were more accurate. Additionally, those with less experience
indicated that high mortality risk scores pushed them to have earlier goals-of-care
conversations than they would have had if they not had the score. The following
examples illustrate this theme:
One time when I should have trusted it and didn’t, we had one patient who we had
jump one day in his score and the only thing that really changed was that his
bilirubin had gone up. I was like I don’t know, he was still pretty well and then of
course that ended up not going very well.
It allowed me to take a moment and be like I think we should have that talk
instead of waiting a day or two to see what happened kind of.
In contrast, participants with vast EOL experiences found the scores to confirm their own
judgment or intuition. Because the scores matched their subjective assessments, the
scores were trusted and provided a level of confidence to coincide with their thoughts;
however, some participants said they might distrust the scores if they differed drastically
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from their assessment using their typical strategies (i.e. trends in labs and vitals and
previous experiences with similar diagnoses). Additionally, those with more experience
voiced concerns that although those with less experience could benefit from having the
scores, they might be reckless with the results by not considering the whole picture and
change their level of care or have premature goals-of-care conversations.
Trends. All participants spoke of the value of looking at trends in data to examine
the ‘big picture’; an admission SOI score alone would not be as helpful as it simply
provides a ‘snapshot.’ Participants were able to follow trends in daily scores and
indicated that they followed the trends as a way for determining whether treatment
interventions were useful or not.
More than mortality prediction. Most participants also described benefits of
using SOFA beyond, but related to, mortality risk. Considering the individual system
scores within the SOFA calculation was beneficial in identifying specific areas in which
additional intervention might or might not be beneficial. This theme is related to ‘context’
too in that individual components of SOFA can provide context for what body system is
causing an increase in mortality risk. Additionally, two of the participants mentioned the
idea of using SOFA scores on the general floors; with the intent to look at scores before
transfer to an ICU to prevent an ICU admission if not in alignment with the patient’s
goals-of-care.
Feasibility and acceptability.
Approval of SOFA. All of the participants indicated they were at least somewhat
familiar with SOFA. Participants also specified their acceptance of SOFA to be used in
calculating SOI scores and its benefit over tools that calculate admission scores only.
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However, the importance of educating users of the scores was highlighted since it could
‘fall into the hands of’ a less-experienced provider. Suggestions were made to provide
SOFA scores in the electronic health record (EHR) that required users to click on it to
learn the score’s conversion to a mortality risk prediction percentage and individual
system scores.
Time as a consideration. Many participants acknowledged the time required for
someone to calculate SOFA scores and indicated they would not be able to perform the
calculations daily. Suggestions were made to have SOFA scores auto-generated in the
EHR. The following example illustrates this theme:
Being provided the score was a great thing because I did not feel like I had the
time to calculate myself on my patients.
Promising opportunity. Most participants revealed they were excited about their
participation in the study, appreciated getting the scores each day, and looked forward to
seeing how the results of the study might change current practice. The following example
illustrates this theme:
It was awesome.
EOL care planning and practice.
‘Fixing’ everyone. Most of the physician participants spoke of their desire to ‘fix’
everyone, that despite the realization that a patient was likely going to die, moving away
from curing was extremely difficult; ‘facing reality’ as one participant indicated. This
was in contrast to reports from two ACNPs who highlighted their years of bedside
nursing as the likely key to their ability to move from ‘curing to caring’ with those ‘very
sick’ patients early in the course of their admission. Overall, however, participants with
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more experience expressed that despite the difficulty, they are already having
conversations with families about poor prognosis on a consistent basis. However,
although the scores gave them confidence in their assessment of the patient’s risk, they
did not change the frequency of goals-of-care conversations for them.
Communication with patient/family. Many participants indicated that sensitivity
is needed when discussing mortality risk with patients and/or their families. A few
participants emphasized that numbers should not be reported to families as they can
distract them and provide false reassurance. Additionally, they indicated that
communication with family about patient prognosis could positively affect the EOL care
provided. The following example illustrates this theme:
A couple of times I couldn’t talk because we had family around and I didn’t bring
it [mortality risk score] up when family were around. That would be more like a
family meeting kind of situation.
Collaboration with team. Many participants indicated that they discussed their
SOFA scores with the interdisciplinary team during daily rounds and the discussion was
well received by the team. This gave them the opportunity to talk with their peers about
different treatment or care options that could impact on the patient’s trajectory.
Additionally, many indicated their approval of having the scores be a formal part of daily
rounds. The following example illustrates this theme:
I think it was generally well received. The people seemed open to it.
Looking at the Big Picture. A couple of the participants contributed the idea that
our focus should be beyond the ICU admission; instead it should be on the patient’s
quality of life even after their ICU stay. They highlighted the need to have goals-of-care
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conversations with all patients with chronic disease regardless of whether their risk for
mortality during that hospitalization was low.
Explanatory Connections
Resulting themes and corresponding exemplars helped to better understand results
of the acceptability and feasibility questionnaire (Figure 3).
Figure 3. Connected Quantitative and Qualitative Findings
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Discussion

Increasing the timeliness of EOL goals-of-care communication in the adult ICU is
warranted to ensure care is in alignment with the wishes of the patient. In addition to the
benefits for the patient, proactive communication reduces anxiety, depression, and posttraumatic stress disorder for family members whose loved one dies in the ICU.24
Furthermore, decreasing EOL resource utilization may decrease emotional and financial
strain experienced by patients and families.25
Implementation of future studies using mortality risk scores in the ICU may fail if
provider perceptions of their use is not considered first.26 This study found SOFA to be a
feasible and acceptable tool for calculating mortality risk prediction scores; it was easy to
use, widely accepted and trusted, and should be considered for use in future studies in
this area of research. Overall, participants indicated that using mortality prediction scores
as part of their daily workflow was acceptable and feasible. However, interview data
indicated that context must not be forgotten when doing so; scores alone should not be
used to initiate EOL goals-of-care communication without first considering what
contributed to the score. In addition, without integrating SOFA scoring into the EHR, the
feasibility of its use in clinical practice will likely be low due to limited time for
providers to calculate the scores themselves.
The use of SOFA mortality risk scores for potentially increasing EOL goals-ofcare conversations appears to be most beneficial for providers with limited ICU
experience. This may result from their limited intuition gained thus far in the setting.
Because more experienced providers indicated that the scores only provided confidence
in their ability to perform accurate subjective assessments of patient mortality risk, it does
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not seem that the scores will increase their probability of meeting with patients and
families earlier. According to their reports, these conversations are already occurring; an
effort for which these providers should be commended. This could be in part due to the
chronic nature of MRICU patients and frequency of EOL occurrences in that unit.
However, it warrants further investigation to learn what would happen if the scores
became part of their everyday evaluation and they were able to witness scores actually
predicting outcomes.
This study is the first known attempt at examining the acceptability and feasibility
of using SOI mortality risk scores for initiating EOL goals-of-care communication.
Although successful in meeting the objectives of the study, difficulties experienced are
worth mentioning. Recruitment for Aim 2 work took longer than expected. Although a
few providers responded to the recruitment email within one week, face-to-face time was
required for recruitment of the remaining participants. One month was required to obtain
the targeted number of participants. A fear of time available to participate during their
busy ICU rotation was the noted barrier; however, when participants learned they would
not have to calculate the scores themselves, many agreed to participate immediately.
Additionally, although the target number of participants recruited for Aim 3 follow-up
interviews was exceeded, it took two months to get all participants scheduled for their
interviews due to their busy schedules.
The single ICU used for this study may limit the generalizability to other types of
ICUs. Additionally, the small nature of this study provides acceptability and feasibility
information only and further limits generalizability. However, the information learned
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may guide future large-scale studies needed to determine the effect of using mortality risk
predictions on patient EOL outcomes.
Conclusion
The use of mortality risk prediction scores as part of routine workflow and practice
for ICU providers was found to be acceptable and feasible and positively impact some
providers’ intentions to change practice, related to goals-of-care communication, as a
result of awareness of the scores. Large-scale studies are needed to determine the effect
of using mortality risk predictions on patient EOL outcomes.
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Figure 1. REDCap Questionnaire: Acceptability and Feasibility of Using SOI
Instrument
Below are seven questions that relate to your use of the severity of illness (SOI) prediction
instrument(s) used for predicting mortality risk for patients in the adult intensive care unit (ICU).
The principal investigator for this study is interested in learning more about your experience
using SOI scores in your routine practice. There are no right or wrong answers to the following
statements. Your answers will remain anonymous and will be compiled with others participating
in this study to help gather data needed for future studies.
Please check the box beside the answer that best describes your agreement or disagreement
with the statement.
1. I clearly understood what the SOI mortality prediction score meant.
__1- Strongly disagree

__2- Disagree

__3-Neither agree or disagree

__4-Agree

__5-Strongly agree

2. I trust that the SOI mortality prediction scores that were provided to me were accurate.
__1- Strongly disagree

__2- Disagree

__3-Neither agree or disagree

__4-Agree

__5-Strongly agree

3. I had enough time to incorporate the SOI mortality prediction score into the plan of care for
my patients.
__1- Strongly disagree

__2- Disagree

__3-Neither agree or disagree

__4-Agree

__5-Strongly agree

4. It is appropriate for me to know an accurate prediction of my patient’s mortality risk.
__1- Strongly disagree

__2- Disagree

__3-Neither agree or disagree

__4-Agree

__5-Strongly agree

5. Knowing my patient’s SOI mortality prediction score made me think about the prognosis
more.
__1- Strongly disagree

__2- Disagree

__3-Neither agree or disagree

__4-Agree

__5-Strongly agree

6. Using SOI mortality prediction scores is an effective way for determining my patient’s
mortality risk.
__1- Strongly disagree

__2- Disagree

__3-Neither agree or disagree

__4-Agree

__5-Strongly agree

7. I believe it would be beneficial to use the results of SOI mortality prediction calculations on a
daily basis.
__1- Strongly disagree

__2- Disagree

__3-Neither agree or disagree

__4-Agree

__5-Strongly agree
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Figure 2. Topics for Focused Interviews

1. Tell me about any experience you have had with patients during the end of life.
2. What data, if any, do you currently use to guide your end-of-life care practice?
3. A few weeks ago, you were provided with Severity of Illness (SOI) mortality
prediction scores for your patients. How did you feel about that? Specifically tell me
about:
a. what made you trust or distrust the score
b. why you thought being provided with the score was a good thing or a bad thing
c. what you did with the information
d. how you think the scores could be incorporated into your daily routine as a
provider
e. any ways in which it may have changed your thinking about your patient’s
prognosis
4. Tell me about any ways your practice may have changed regarding communication
with patients and/or families about EOL goals-of-care since your experience with
using SOI mortality prediction scores. If your practice has not changed, tell me about
any intentions you have for changing (or not) based on the experience with the SOI
scores.
5. When caring for an ICU patient with a high risk for mortality, tell me about your
perceived ability to impact their EOL experience?
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Summary
This dissertation has provided evidence for the feasibility, acceptability, and
preliminary impact of using Severity of Illness (SOI) mortality prediction scores for
initiating end-of-life (EOL) goals-of-care communication in the adult Intensive Care Unit
(ICU).
Overview of Manuscripts
This dissertation includes three manuscripts:
An integrative review of severity of illness scoring systems used to predict
hospital mortality for patients admitted to the adult intensive care unit. This
integrative review synthesizes the literature that evaluates the psychometric properties of
existing SOI scoring systems and their ability to predict mortality in the adult ICU
population as the basis for clinical care and provider-patient/family communication. A
total of 969 articles were identified with seven meeting all inclusion criteria. Based on
discrimination alone, this review found APACHE IV to be superior, but the VA ICU,
SICULA, and SOFA Max were close with ‘very good’ discrimination. This review
provided the foundational knowledge needed in the selection of SOI systems that were
used for the aim 1 focus group. Based on the findings from this review and
implementation feasibility within the study setting, four SOI scoring systems (MPM III,
APACHE IV, SOFA, SAPS III) were presented to the focus group participants; SOFA
was ultimately chosen and was used for the study examining the feasibility and
acceptability of using mortality risk scores in the ICU as the basis for EOL
communication.
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Supporting surrogates of incapacitated individuals throughout the research
trial – From initial consent to study closure and beyond. This integrative review
discusses and critiques the current state of knowledge related to interventions that can
guide researchers in reducing surrogate burden throughout the research trial. A total of 25
articles met inclusion criteria for review. Analysis of the articles revealed six levels of
intervention, from the personal ‘Direct Care of the Surrogate’ to the population-based
‘Legal/Regulatory’ and provides a framework to assist researchers and other interested
parties when surrogates are relied upon for decision making regarding research
participation. This review provided foundational knowledge needed when designing the
dissertation study. Knowledge gained from this review led to decisions on how SOI
scores would be reported to providers in aim 2. Specifically, a design was used that
protected surrogates from unnecessary burden during the study.
The EFFECT study: The acceptability, feasibility, and potential impact of
using mortality prediction scores for initiating end-of-life goals of care
communication in the adult intensive care unit. This manuscript details the dissertation
study. This mixed-methods study evaluated 1) the acceptability and feasibility of
providers’ use of patient mortality prediction scores as part of routine practice, and 2)
providers’ intentions to change practice, related to goals-of-care communication, as a
result of awareness of the scores. Overall, use of mortality risk prediction scores as part
of routine workflow and practice was found to be acceptable and feasible – providers
agreed to participate, patient mortality risk were evaluated, and overall, participants
found use of daily mortality prediction scores possible in their setting. However, there
was some disagreement related to the use of SOFA scores as an effective way for
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determining patient mortality risk. Based on themes that emerged from interviews,
providers with limited ICU experience were eager and accepting of the mortality risk
scores while those with vast experience found the scores to be an adjunct to their own
intuition; though all acknowledged the benefit of looking at daily scores or ‘trends’. The
most substantial of all themes identified was the need to consider SOFA scores in relation
to patient context; a number alone should not determine mortality risk and whether a
goals-of-care conversation needs to occur. Use of SOFA scores for potentially increasing
EOL goals-of-care conversations appears to be most beneficial for providers with limited
ICU experience.
Limitations and Lessons Learned
This dissertation is the first known attempt at examining the acceptability and
feasibility of using SOI mortality risk scores for initiating EOL goals-of-care
communication. Although successful in meeting the objectives of the study, difficulties
experienced are worth mentioning. Recruitment for Aim 2 took longer than expected.
Although a few providers responded to the recruitment email within one week, face-toface time was required for recruitment of the remaining participants. One month was
required to obtain the targeted number of participants. A fear of time available to
participate during their busy ICU rotation was the noted barrier; however, when
participants learned they would not have to calculate the scores themselves, many agreed
to participate immediately. Additionally, although the target number of participants
recruited for Aim 3 follow-up interviews was exceeded, it took two months to get all
participants scheduled for their interviews due to their busy schedules.
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The results of the study indicated that providers found use of SOI scores to be
acceptable and feasible. However, the time required for the principal investigator (PI) to
calculate daily scores should be highlighted. Many participants acknowledged the time
required for someone to calculate Sequential Organ Failure Assessment (SOFA) scores
and indicated they would not be able to perform the calculations daily. Therefore, without
integrating SOFA scoring into the electronic health record (EHR), the feasibility of its
use in clinical practice will likely be low due to limited time for providers to calculate the
scores themselves.
The single ICU used for this study may limit the generalizability to other types of
ICUs. Additionally, the small nature of this study provided acceptability and feasibility
information only and further limits generalizability. However, the information learned
may guide future large-scale studies needed to determine the effect of using mortality risk
predictions on patient EOL outcomes.
Importance of Theory
For this dissertation, self-efficacy theory(1) provided an understanding of how
study providers’ beliefs concerning his or her abilities affected their own behavior .(2)
Using self-efficacy as the theoretical underpinning, providers with high self-efficacy
believe that they are capable of positively impacting the quality of their patient’s EOL
and are motivated to do so. However, providers with low self-efficacy do not believe they
are capable of positively impacting the quality of their patient’s EOL, and therefore, are
not motivated to put forth such effort. In future intervention studies that build on the
results of this study, the PI will use self-efficacy theory to guide changes in
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interdisciplinary team members’ behaviors regarding EOL goals-of-care communication
and thus test this theory in a new domain.
Research Trajectory
There are several areas for future research based on this dissertation work. The
ultimate goal is to design interventions aimed at improving the quality of dying and death
experienced by patients in the adult ICU. This initial study provides crucial foundational
knowledge related to the acceptability and feasibility of using mortality risk scores for
initiating EOL goals-of-care communication. Next steps will involve use of SOFA
mortality risk scores on a larger scale to examine its effect on timeliness and frequency of
EOL goals-of-care communication. Furthermore, determining the impact of earlier and
more frequent communication on the patient’s quality of dying and death is of interest.
Contribution of Research
The results of this dissertation point to several implications for research. The
integrative review examining SOI mortality risk scoring systems validates the use of
multiple SOI systems for predicting ICU mortality that can be incorporated into research
even beyond their use for initiating EOL goals-of-care communication. Additionally, the
integrative review examining interventions used for reducing surrogate burden
throughout the research trial provides a framework that any researcher can consider when
designing studies that includes incapacitated persons as potential participants.
Findings from this current work also lead to implications for clinical care. The
dissertation study found the use of mortality risk prediction scores by ICU providers to be
acceptable and feasible. Furthermore, explanatory follow-up interviews uncovered some
preliminary positive outcomes of using the daily SOFA scores; some providers reported
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the scores encouraged them to have earlier EOL goals-of-care communication with
families. Current deficiencies in EOL care communication can compromise quality of
EOL care(3) and increase resource utilization.(4,5) Although future work that builds upon
the results of this study is needed, the implications may have the ability to help form
standards for EOL communication in the adult ICU so these inadequacies can be
addressed.
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Appendix E: Focus Group Recruitment Email
We are looking for participants for a research study regarding the acceptability,
feasibility, and potential impact of using a severity of illness (SOI) mortality prediction
instrument for initiating end-of-life goals-of-care communication in the adult intensive
care unit. You are being asked to participate in this study because you are a provider in
the Medical-Respiratory Intensive Care Unit (MRICU) that is responsible for total patient
care, including prognosis.
Prior to asking providers to use SOI scores in their everyday practice to examine its
impact, we need help with determining which instrument, or combination of instruments,
is best for use in the MRICU, given your perceived feasibility of its use. In this arm of the
study, you will be asked to participate in a focus group with five other MRICU providers
(MD, NP, PA combination). In the focus group, you will be given a table that compares
all four potential instruments and will be asked to discuss your perceived feasibility of
using each instrument and rank them in order of preference. The focus group is
anticipated to last less than two hours. The focus group will be audio recorded as a
backup and the audio file will be stored in a secure web-based data capture system. In
addition, all study participants will be asked to complete an online demographic form that
consists of items related to age, race/ethnicity, gender, health discipline, years of practice,
and previous experience with end-of-life care. Demographic data will only be used for
descriptive purposes when describing the results of the study. All data collected will be
kept confidential.
You may not get any direct benefit from this study, but the information we learn from
people in this study may help us design standards for communication with patients and
their families during the patient’s end-of-life in the ICU. Participants will be
compensated for their time with a meal during the focus group.
If you are interested in participating in this study, please contact the principal
investigator, either by email or phone. We appreciate your consideration in partaking in
this important study.
Shelly Orr, MSN, RN, CNE
Clinical Assistant Professor, VCU School of Nursing
Principal Investigator
Phone: (804) 221-5159
Email: mlorr@vcu.edu
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Appendix F: Focus Group Consent Form
RESEARCH SUBJECT INFORMATION AND CONSENT FORM
TITLE: The Acceptability, Feasibility, and Potential Impact of Using a Severity of
Illness Mortality Prediction Instrument for Initiating End-of-Life Goals of Care
Communication in the Adult Intensive Care Unit
VCU IRB NO.: HM20007357
If any information contained in this consent form is not clear, please ask the
study staff to explain any information that you do not fully understand. You may
take home an unsigned copy of this consent form to think about or discuss with
family or friends before making your decision.
PURPOSE OF THE STUDY
The purpose of this research study is to find out if patient mortality prediction
scores can and should be used as a part of your routine workflow and practice as
a healthcare provider.
You are being asked to participate in this study because you are a provider in the
Medical-Respiratory Intensive Care Unit (MRICU) that is responsible for total
patient care, including prognosis.
DESCRIPTION OF THE STUDY AND YOUR INVOLVEMENT
If you decide to be in this research study, you will be asked to sign this consent
form after you have had all your questions answered and understand what will
happen to you.
In this initial phase of the study, you will be asked to participate in a focus group
with five other MRICU providers to evaluate four mortality prediction instruments
to determine which instrument, or combination of instruments, is best for the
MRICU. Participants will be given a table that compares four available
instruments and will be asked to discuss perceived usability of each instrument.
Participants will be asked to verbally provide ranking scores for the instruments.
The length of the focus group is anticipated to be approximately two hours. The
focus group will be audio recorded in case further analysis related to rankings
needs to occur and the audio files will only be retrievable only by the Principal
investigator (PI) or research assistant (RA). The PI will notify all participants via
email which instrument(s) were selected. If there are any participant concerns, an
additional focus group will be held to reach consensus. In addition, all study
participants will be asked to complete an online demographic form that consists
of items related to age, race/ethnicity, gender, health discipline, years of practice,
and previous experience with end-of-life care. Demographic data will only be
used for descriptive purposes when describing the results of the study.
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Significant new findings developed during the course of the research that may
relate to your willingness to continue participation will be provided to you.
RISKS AND DISCOMFORTS
Sometimes talking about patient mortality risk causes people to become upset.
You do not have to talk about anything you do not want to talk about, and you
may choose to leave the focus group at any time. If you become upset, the study
staff will give you names of counselors to contact so you can get help in dealing
with these issues. Also, because your time as a provider is already limited, the
time required to participate in this study may make you feel overwhelmed.
Although the time required to participate is minimal, you may choose to leave the
study at any time.
BENEFITS TO YOU AND OTHERS
You may not get any direct benefit from this study, but, the information we learn
from people in this study may help us design standards for communication with
patients and their families during the patient’s end-of-life in the ICU.
COSTS
There are no costs for participating in this study other than the time you will
spend partaking in the focus group discussion.
PAYMENT FOR PARTICIPATION
You will receive a meal during the focus group meeting.
ALTERNATIVES
The only alternative for this study is not to participate.
CONFIDENTIALITY
Potentially identifiable information about you will consist of demographics and
audio recordings. Data is being collected only for research purposes.
A secure web-based data capture system will be used to collect demographic
data, as well as store audio recordings. The audio recording will be deleted once
transcription occurs and no names will be recorded. Your data will be identified
by ID numbers, not names or other identifiers, and stored separately from
research data in a locked research area. All personal identifying information will
be kept in password-protected files and these files will be deleted one year after
completion of the study. Consent forms will be destroyed three years after study
completion. Study data, without identifiers, will be kept indefinitely on a
password-protected computer. Access to all data will be limited to study
personnel.
We will not tell anyone the responses you give us; however, information from the
study and the consent form signed by you may be looked at or copied for
research or legal purposes, or by Virginia Commonwealth University. Personal
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information about you might be shared with or copied by authorized officials of
the Department of Health and Human Services or other federal regulatory
bodies.
What we find from this study may be presented at meetings or published in
papers, but your name will not ever be used in these presentations or papers.
VOLUNTARY PARTICIPATION AND WITHDRAWAL
You do not have to participate in this study. If you choose to participate, you may
stop at any time without any penalty. You may also choose not to answer
particular questions that are asked in the study.
Your participation in this study may be stopped at any time by the study staff
without your consent. The reasons might include:
• the study staff thinks it is necessary for your health or safety;
• you have not followed study instructions;
• the sponsor has stopped the study; or
• administrative reasons require your withdrawal.
QUESTIONS
If you have any questions, complaints, or concerns about your participation in
this research, contact:
Shelly Orr, MSN, RN, CNE
Principal Investigator
Phone: (804) 221-5159
Email: mlorr@vcu.edu
The researcher/study staff named above is the best person(s) to call for
questions about your participation in this study.
If you have any general questions about your rights as a participant in this or any
other research, you may contact:
Office of Research
Virginia Commonwealth University
800 East Leigh Street, Suite 3000
P.O. Box 980568
Richmond, VA 23298
Telephone: (804) 827-2157
Contact this number to ask general questions, to obtain information or offer input,
and to express concerns or complaints about research. You may also call this
number if you cannot reach the research team or if you wish to talk with someone
else. General information about participation in research studies can also be
found at http://www.research.vcu.edu/irb/volunteers.htm.
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CONSENT
I have been given the chance to read this consent form. I understand the
information about this study. Questions that I wanted to ask about the study have
been answered. My signature says that I am willing to participate in this study. I
will receive a copy of the consent form once I have agreed to participate.

Participant name (Printed)

Participant signature

Date

Name of Person Conducting Informed Consent Discussion (Printed)

Signature of Person Conducting Informed Consent Discussion

Date

Principal Investigator Signature (if different from above)

Date
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Appendix G: Demographic Information Questionnaire Email

Thank you for your participation in the study The Acceptability, Feasibility, and
Potential Impact of Using a Severity of Illness Mortality Prediction Instrument for
Initiating End-of-Life Goals of Care Communication in the Adult Intensive Care Unit
(VCU IRB NO.: HM20007357).
As part of your participation in this study, we are asking that you complete a
demographic questionnaire. Your answers will be kept confidential and available to the
study staff only. Your answers will be combined with others and used when reporting the
descriptive results of the study.
If you have any questions or concerns about this questionnaire, contact:
Shelly Orr, MSN, RN, CNE, Principal Investigator
Phone: (804) 221-5159
Email: mlorr@vcu.edu
Please complete the questionnaire within the next week by clicking on the following
link. *Insert REDCap Link Here
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Appendix H: Participant Demographic Data Form (REDCap)

Age

Health Discipline

Age at last birthday: ________ years

__ Acute Care Nurse Practitioner (ACNP)
__ Physician Assistant (PA)
__ Physician
__Intern

__Resident

__Fellow

__Attending

Gender

Years of Practice in this Discipline

__ Male

Years in your profession: ________ years

__ Female

If less than one year, specify months in your
profession: ________ months

Race/Ethnicity

Previous Experience with End-of-Life
(EOL)

__ American Indian or Alaska Native

__ None

__ Asian

__ Personal (i.e. loss of someone close to you)

__ Black or African American

__ Professional
__ Coursework on EOL care
__ Hands-on experience with patients
during their EOL (including training in

__ Hispanic or Latino
__ Native Hawaiian or Other Pacific Islander

palliative care)

__ Other – Please specify: _____________
__ White
__ Other
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Appendix I: Focus Group Principal Investigator Guide

1. The purpose of this focus group is to have you all evaluate four valid severity of
illness (SOI) instruments, used to calculate patient mortality risk, to determine
which instrument, or combination of instruments, is the best fit for use in the
MRICU, given your perceived feasibility of use as providers in the unit. As the
Principal Investigator of this study, I will assume the moderator role of this focus
group to keep the flow of the conversation on target.
*A copy of the table that compares the four SOI instruments (Appendix B) is
distributed to all focus group participants.

2. Questions for the focus group:
a. How practical/feasible is the use of the MPM III in the MRICU?
b. How practical/feasible is the use of the APACHE IV in the MRICU?
c. How practical/feasible is the use of the SOFA in the MRICU?
d. How practical/feasible is the use of the SAPS III in the MRICU?
e. What are your preferences regarding an admission score only versus an
admission score plus a daily score (i.e. SOFA)?
f. Provide ranking scores for the instruments (if needed).

3. The PI will notify all participants via email which instrument(s) were selected. If
there are any participant concerns, an additional focus group will be held to reach
consensus.
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Appendix J: Focus Group SOI Instrument Comparison Table
Severity of
Illness (SOI)
Instrument
Mortality
Probability
Admission
Model
(MPMo III)

About the Instrument….

Has 16 predictor variables plus seven interaction terms that include
physiological variables, chronic diagnoses, acute diagnoses, age,
code status (and whether the patient has received CPR),
mechanical ventilation status, and whether a medical or
unscheduled surgical admit occurred (Higgins et al., 2007a).
Estimates mortality probability at hospital discharge using data
obtained at the time of or within 1 hour of ICU admission; values are
assumed to be normal when measurements have not been
obtained (Higgins et al., 2009).
Excludes certain patient subsets, including cardiac surgery,
myocardial infarction, burn, less 18 years old, and ICU
readmissions (Higgins et al., 2009).
Because data are collected at ICU arrival, may be less potential for
the score to be influenced by care received after admission to the
ICU (Kuzniewicz et al., 2008).
74,578 patient records from Project IMPACT ICUs (135 ICUs at 98
hospitals including mostly US, but 3 were Canada and 1 Brazil)
were used for development of instrument; 50,307 patient records
were used for validation (AUROC= 0.823; H-L statistic= 11.62, p=
0.31) (Higgins et al., 2007b).
MPMo III not readily available online, but the MPM II is. The MPMo
III takes around 11 minutes to manually abstract required data,
requiring yes/no answers only (Kuzniewicz et al., 2008). However,
this does not account for analysis time requirements.
Cerner supports collection of variables used by the MPMo III and
markets it’s use (Kramer, Higgins, & Zimmerman, 2014).

Acute
Physiology and
Chronic Health
Evaluation
(APACHE IV)

Incorporates 142 predictor variables, 116 admission diagnoses, and
17 physiological variables (Zimmerman, Kramer, McNair, & Malila,
2006). Predictor variables include age, acute physiology score
variables (labs, vital signs, GCS, chronic health variables, ICU
admission diagnosis and source, length of stay prior to ICU
admission, GCS score rescaled, and PaO2/FiO2 ratio. Also entered
into the system are data on whether the patient had emergency
surgery, mechanical ventilation, or an inability to assess GCS. Also
collected are data on gender, whether the patient is post-coronary
artery bypass grafting (CABG), number of any grafts, whether an
internal mammary graft was used, and whether the patient had
diabetes prior to the CABG or an MI during that hospitalization.
Uses physiologic data from the first 24 hours after ICU admission
(Kuzniewicz et al., 2008). Scores based on worse measurements
for each component on ICU day 1 (Zimmerman et al., 2006).
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Severity of
Illness (SOI)
Instrument

About the Instrument….

Initially validated in a study consisting of a non-randomized
observational cohort of 131,618 consecutive patients admitted to
104 ICUs in 45 US hospitals (AUROC= 0.88; H-L statistic= 16.8, p=
0.8) (Zimmerman et al., 2006). Only patients excluded were those
with burns, those admitted for less than 4 hours, less than 16 years
old, or those admitted after transplant operations (except for renal
and hepatic transplants). Only included first ICU admission and
excluded ICU transfer patients (Zimmerman et al., 2006). ICU
locations were diverse across US, teaching versus non-teaching,
number of beds, and type (medical, trauma, cardiac, neuro)
(Zimmerman et al., 2006).
Publically accessible web-based option calculates predicted
mortality when variables are manually entered (Zimmerman et al.,
2006).
Training manual is available and reliability can be enhanced by auto
collection of variables through EHR (Zimmerman et al., 2006).
Cerner owns the registered trademark for APACHE and markets
the APACHE IV instrument (Kramer et al., 2014). Require purchase
of APACHE system to be automatically calculated in Cerner.
Sequential
Organ Failure
Assessment
(SOFA)

Assigns 1-4 points to the following organ systems depending on the
level of organ dysfunction: circulatory, respiratory, renal,
hematology, hepatic, and central nervous system (Minne,
Ludikhuize, De Jonge, De Rooij, & Abu-Hanna, 2011).
Differentiations are made based on the scores used (Minne et al.,
2008). The total max SOFA is the sum of the highest scores per
individual organ system during the entire ICU stay. The max SOFA
is the highest total SOFA measured in a pre-specified time interval,
and the mean SOFA is the average of all total SOFA scores in the
pre-specified time interval. The delta SOFA is the total max minus
admission SOFA. Data are typically collected upon ICU admission
and throughout the ICU stay, with the most abnormal values for
each day being recorded (Vincent et al., 1998).
Admission scores calculated using the most abnormal values from
the first 24 hours after ICU admission (Minne et al., 2008).
In a systematic review published in 2008, the highest AUC’s were
reported for max SOFA (0.792-0.922) and total max SOFA (0.690.921) and the lowest AUC’s for delta SOFA (0.51-0.828). The H-L
statistics for total max SOFA (0.33-0.95) were superior to delta and
mean SOFAs (all being <0.05). Many studies combined SOFA with
other models (APACHE II, SAPS II) which resulted in improved
performance and discrimination compared to the models alone
(Minne et al., 2008).
Web-based option calculates predicted mortality when variables are
manually entered.
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Severity of
Illness (SOI)
Instrument

About the Instrument….

Simplified Acute
Physiology
Score

Predictor variables for this model include age, comorbidities, preICU location, pre-ICU length of stay, pre-ICU major therapeutics,
reason for ICU admission, planned/unplanned admission, infection
at ICU admission, surgical status, site of surgery if applicable, GCS,
total bilirubin, body temperature, creatinine, heart rate, leukocytes,
pH, platelets, systolic blood pressure, and ventilation/oxygenation
with scores ranging from 0-217 (Metnitz et al., 2005; Moreno et al.,
2005).
Data are collected within one hour of ICU admission in an attempt
to dissociate evaluation of the patient from evaluation of the ICU;
Data collected within one hour of ICU admission provides
probability of death during hospitalization.

(SAPS III)

Any data not available assumed normal (Moreno et al., 2005).
Developed with data from 19,577 ICU patients in 35 countries
(AUROC= 0.848; H-L statistic= 14.29, p= 0.16) (Moreno et al.,
2005).
Can be computed manually or integrated into a computerized data
retrieval system. Requires adaptation of some variables that cannot
be directly linked to EHR (Moreno et al., 2005).

129
Appendix K: Acceptability & Feasibility Questionnaire and Follow-Up Interview
Recruitment Email
We are looking for participants for a research study examining whether patient mortality
prediction scores can and should be used as a part of routine workflow and practice as a
healthcare provider. You are being asked to participate in this study because you are, or
will soon be, a provider in the Medical-Respiratory Intensive Care Unit (MRICU) that is
responsible for total patient care, including prognosis.
In this study, you will be asked to receive mortality prediction scores for your patients for
10 consecutive days (scores provided by the study investigator or assistant on a note
card), and complete a seven-item online questionnaire about your experience afterwards.
The questionnaire is expected to take less than ten minutes to complete and will ask about
your experience with the mortality prediction scores, such as whether you understood
what the score meant and whether you thought knowing the score was beneficial.
Following completion of the questionnaire, you will be contacted to ask for your
additional participation in a follow-up interview. If you choose to do so, you will be
asked to partake in an individual face-to-face interview with the study’s investigator. The
interview is expected to take less than one hour and will ask about your experience with
the mortality prediction scores and how your practice may or may not have changed as a
result of knowing those scores. The interviews will be audio recorded so we are sure to
get everyone’s ideas, but no names will be recorded on the tape. In addition, all study
participants will be asked to complete an online demographic form that consists of items
related to age, race/ethnicity, gender, health discipline, years of practice, and previous
experience with end-of-life care. Demographic data will only be used for descriptive
purposes when describing the results of the study. All data collected will be kept
confidential.
You may not get any direct benefit from this study, but the information we learn from
people in this study may help us design standards for communication with patients and
their families during the patient’s end-of-life in the ICU. Participants will be
compensated for their time with gift cards for Au Bon Pain Café Bakery.
If you are interested in participating in this study, please contact the principal
investigator, either by email or phone. We appreciate your consideration in partaking in
this important study.
Shelly Orr, MSN, RN, CNE
Clinical Assistant Professor, VCU School of Nursing
Principal Investigator
Phone: (804) 221-5159
Email: mlorr@vcu.edu
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Appendix L: Acceptability & Feasibility Questionnaire and Follow-Up Interview
Consent Form
RESEARCH SUBJECT INFORMATION AND CONSENT FORM
TITLE: The Acceptability, Feasibility, and Potential Impact of Using a Severity of
Illness Mortality Prediction Instrument for Initiating End-of-Life Goals of Care
Communication in the Adult Intensive Care Unit
VCU IRB NO.: HM20007357
If any information contained in this consent form is not clear, please ask the
study staff to explain any information that you do not fully understand. You may
take home an unsigned copy of this consent form to think about or discuss with
family or friends before making your decision.
PURPOSE OF THE STUDY
The purpose of this research study is to find out if patient mortality prediction
scores can and should be used as a part of your routine workflow and practice as
a healthcare provider.
You are being asked to participate in this study because you are a provider in the
Medical-Respiratory Intensive Care Unit (MRICU) that is responsible for total
patient care, including prognosis.
DESCRIPTION OF THE STUDY AND YOUR INVOLVEMENT

If you decide to be in this research study, you will be asked to sign this consent
form after you have had all your questions answered and understand what will
happen to you.
In this study, you will be asked to receive mortality prediction scores for your
patients for 10 consecutive days. The scores will be provided to you by the study
investigator or assistant on a note card each morning before interdisciplinary
rounds. To protect patient confidentiality, the note cards will only have patient
room numbers and mortality prediction scores on them and you will be asked to
place them in the shredder box before leaving the unit at the end of the day. To
help you with interpretation of the score, a reference card will be provided to you
upon study enrollment. Following the ten days, you will then be asked to
complete a seven-item online questionnaire about your experience. The
questionnaire is expected to take less than ten minutes to complete and will ask
about your experience with the morality prediction scores, such as whether you
understood what the score meant and whether you thought knowing the score
was beneficial. Following completion of the questionnaire, you will be contacted
to ask for your additional participation in a follow-up interview. If you choose to do
so, you will be asked to partake in an individual face-to-face interview with the
study’s investigator. The interview is expected to take less than one hour and will
ask about your experience with the mortality prediction scores and how your
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practice may or may not have changed as a result of knowing those scores. The
interviews will be tape recorded so we are sure to get everyone’s ideas, but no
names will be recorded on the tape. In addition, all study participants will be
asked to complete an online demographic form that consists of items related to
age, race/ethnicity, gender, health discipline, years of practice, and previous
experience with end-of-life care. Demographic data will only be used for
descriptive purposes when describing the results of the study.
Significant new findings developed during the course of the research that may
relate to your willingness to continue participation will be provided to you.
RISKS AND DISCOMFORTS
Sometimes talking about patient mortality risk causes people to become upset.
You do not have to talk about anything you do not want to talk about, and you
may choose not to answer questions or leave the interview at any time. If you
become upset, the study staff will give you names of counselors to contact so
you can get help in dealing with these issues. Also, because your time as a
provider is already limited, the time required to participate in this study may make
you feel overwhelmed. Although the time required to participate is minimal, you
may choose to leave the study at any time.
BENEFITS TO YOU AND OTHERS
You may not get any direct benefit from this study, but, the information we learn
from people in this study may help us design standards for communication with
patients and their families during the patient’s end-of-life in the ICU.
COSTS
There are no costs for participating in this study other than the time you will spend filling
out questionnaires and partaking in an interview.
PAYMENT FOR PARTICIPATION
You will receive a $25.00 gift card for Au Bon Pain Café Bakery for completing the
demographic form and questionnaire. If you chose to also participate in the follow-up
interview, you will receive an additional $25.00 gift card for Au Bon Pain. The study’s
investigator or assistant upon participation completion will provide gift cards.

ALTERNATIVES
The only alternative for this study is not to participate.
CONFIDENTIALITY

Potentially identifiable information about you will consist of demographics,
questionnaire responses, and interview notes and recordings. Data is being
collected only for research purposes.
A secure web-based data capture system will be used to collect demographic
and questionnaire data, as well as store interview recordings and transcriptions.
Interview audio recordings will be deleted once transcription occurs and no
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names will be recorded. Your data will be identified by ID numbers, not names or
other identifiers, and stored separately from research data in a locked research
area. All personal identifying information will be kept in password-protected files
and these files will be deleted one year after completion of the study. Consent
forms will be destroyed three years after study completion. Study data, without
identifiers, will be kept indefinitely on a password-protected computer. Access to
all data will be limited to study personnel.
We will not tell anyone the answers you give us; however, information from the
study and the consent form signed by you may be looked at or copied for
research or legal purposes, or by Virginia Commonwealth University. Personal
information about you might be shared with or copied by authorized officials of
the Department of Health and Human Services or other federal regulatory
bodies.
What we find from this study may be presented at meetings or published in
papers, but your name will not ever be used in these presentations or papers.
VOLUNTARY PARTICIPATION AND WITHDRAWAL

You do not have to participate in this study. If you choose to participate, you may
stop at any time without any penalty. You may also choose not to answer
particular questions that are asked in the study.
Your participation in this study may be stopped at any time by the study staff
without your consent. The reasons might include:
• the study staff thinks it necessary for your health or safety;
• you have not followed study instructions;
• the sponsor has stopped the study; or
• administrative reasons require your withdrawal.
QUESTIONS
If you have any questions, complaints, or concerns about your participation in this
research, contact:
Shelly Orr, MSN, RN, CNE
Principal Investigator
Phone: (804) 221-5159
Email: mlorr@vcu.edu
The researcher/study staff named above is the best person(s) to call for questions about
your participation in this study.
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If you have any general questions about your rights as a participant in this or any other
research, you may contact:
Office of Research
Virginia Commonwealth University
800 East Leigh Street, Suite 3000
P.O. Box 980568
Richmond, VA 23298
Telephone: (804) 827-2157

Contact this number to ask general questions, to obtain information or offer input,
and to express concerns or complaints about research. You may also call this
number if you cannot reach the research team or if you wish to talk with someone
else. General information about participation in research studies can also be
found at http://www.research.vcu.edu/irb/volunteers.htm.
CONSENT

I have been given the chance to read this consent form. I understand the
information about this study. Questions that I wanted to ask about the study have
been answered. My signature says that I am willing to participate in this study. I
will receive a copy of the consent form once I have agreed to participate.

Participant name (Printed)

Participant signature

Date

Name of Person Conducting Informed Consent Discussion (Printed)

Signature of Person Conducting Informed Consent Discussion

Date

Principal Investigator Signature (if different from above)

Date
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Appendix M: EFFECT Study Badge Buddy for Participants Receiving SOI
Mortality Risk Scores

EFFECT Study (End-oF-liFE-CommunicaTion)
How do I use the Sequential Organ Failure Assessment (SOFA)
score that’s been reported to me?
SOFA is a mortality prediction tool that assigns points depending on the level of
organ dysfunction
Scores are calculated using the most abnormal values from the previous 24
hours; values are obtained from the EHR
SOFA scores can be converted to an estimate of mortality risk – This is the %
that’s been reported to you for patients admitted under your care

For questions about the EFFECT Study, contact the PI, Shelly Orr
(804-221-5159; mlorr@vcu.edu)
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Appendix N: SOFA SOI Instrument- Online Calculator
(http://clincalc.com/icumortality/sofa.aspx)
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Appendix O: Calculating SOFA Scores User’s Manual
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140
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Appendix P: Daily Cards Provided to Participants Receiving SOFA Mortality Risk
Scores

Participant:
Date:

Date:

Date:

For: ______

______ %

______ %

______ %

For: ______

______ %

______ %

______ %

For: ______

______ %

______ %

______ %

For: ______

______ %

______ %

______ %
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Appendix Q: Acceptability & Feasibility Questionnaire Reminder Email

Thank you for your participation in the study The Acceptability, Feasibility, and
Potential Impact of Using a Severity of Illness Mortality Prediction Instrument for
Initiating End-of-Life Goals of Care Communication in the Adult Intensive Care Unit
(VCU IRB NO.: HM20007357).
For the previous 10 days, you have received mortality prediction scores for your patients
in the Medical Respiratory ICU (MRICU). Following your experience with these scores,
you are now being asked to complete a seven-item online questionnaire about your
experience. The questionnaire is expected to take less than ten minutes to complete.
Following completion of the questionnaire, you will receive compensation for your
participation and you will be contacted to ask for your additional participation in a
follow-up interview.
Please remember that data is being collected for research purposes only and no responses
will be linked to your identifying information. A secure web-based data capture system is
being used to collect the questionnaire data.
If you have any questions or concerns about this questionnaire, contact:
Shelly Orr, MSN, RN, CNE, Principal Investigator
Phone: (804) 221-5159
Email: mlorr@vcu.edu
Please complete the questionnaire within the next week by clicking on the following
link. *Insert REDCap Link Here

